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To investigate patient perceptions and acceptance of the three whole-body imaging modalities 
used for diagnosing myeloma; radiographic skeletal survey (RSS), low-dose whole-body 
computed tomography (LD-WBCT) and whole-body magnetic resonance imaging (WB-MRI). 
The secondary aim was to explore the factors affecting the acceptance of whole-body imaging 
for myeloma. 
Methods and Materials 
60 participants (median age = 58.5 years) were recruited from three NHS trusts and myeloma 
support groups via social media. They completed a survey that included scoring different 
aspects of their experiences of whole-body imaging on a 5-point rating scale. The Kruskal-
Wallis test was used to analyse differences in the distribution of scores. Participants were 
invited to provide open text responses for thematic analysis. 
Results 
All modalities demonstrated high levels of acceptability (median score = 4). WB-MRI was 
perceived as more stressful (p = 0.008) and claustrophobic (p = <0.001) than RSS and LD-
WBCT. Thematic analysis of open text responses showed patients understood the importance 
of imaging for diagnosis but were concerned about existing bone damage, pain experienced 
during imaging and the diagnostic outcome. The duration of WB-MRI had a negative effect on 
acceptance. Respondents were averse to the physical manipulation required for RSS, whilst 
remaining stationery was perceived as a benefit of LD-WBCT and WB-MRI. Staff interactions 
had both positive and negative effects on acceptance. 
Conclusions 
While myeloma patients perceived psychological and physical burdens associated with whole-
body imaging, they accepted its role in facilitating diagnosis. Staff support has a significant 
influence on imaging acceptance, and imaging choice should be tailored to individual needs. No 
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1.1 Context and Rationale 
The purpose of this study is to investigate patient acceptance and experiences of the different 
whole-body imaging modalities used within the National Health Service (NHS) for the diagnosis 
of myeloma in the United Kingdom (UK). Myeloma is an adult haematological cancer of the 
plasma cells found in the bone marrow which causes multiple bone lesions throughout the 
skeleton; therefore, the condition is often referred to as ‘multiple myeloma’ (Hansford and 
Silbermann 2018: 1). Radiological imaging is required to identify myeloma-related bone lesions 
for diagnosing and staging the disease and to guide effective treatment. 
The three whole-body imaging techniques used for identifying myeloma related bone lesions are 
radiographic skeletal survey (RSS), low-dose whole-body computed tomography (LD-WBCT) 
and whole-body magnetic resonance imaging (WB-MRI). The author of this thesis is a 
Diagnostic Radiographer with experience in all three of these imaging modalities. Since 2002, 
the author has performed innumerable RSS examinations for the diagnosis of multiple 
myeloma, and in 2009 began to specialise in CT and MRI. It was not until 2016 that the author 
first performed WB-MRI examinations for the diagnosis of myeloma as part of a new service 
being developed within his department at that time. In early 2018 the author assisted with the 
development of a local LD-WBCT imaging protocol so that this imaging method for myeloma 
could also be offered. This detailed knowledge of each imaging modality and their fundamental 
differences, alongside an awareness that all three are still performed in the NHS, led the author 
to question if there was a clear consensus as to which imaging modality should be the first 
choice and whether RSS should be superseded by the latest whole-body imaging techniques. 
Research investigating the primary imaging choice for diagnosing myeloma considers the 
question from the perspective of diagnostic value and a definitive consensus has not been 
made (Minarik et al. 2016; Regelink et al. 2013; Wolf et al. 2014). These studies have not 
considered the imaging choice from the perspective of the service users. The authors broad 
range of anecdotal evidence regarding individuals’ experiences of all three whole-body imaging 
modalities led to an interest in attempting to understand the patients’ acceptability of these 
examinations, and whether this could inform the primary imaging choice. 
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Diagnostic radiographers are in a unique position to address the question of ‘which is the best 
form of diagnostic imaging’ from a patient perspective. Radiographers interact with the patient 
throughout their examination and form part of the patients’ imaging experience. The issue of 
diagnostic value will always be of most importance to the referring clinicians, whilst the technical 
parameters around each imaging modality are the domain of equipment manufacturers and 
medical physicists. Diagnostic radiographers have a key interest and involvement in both 
diagnostic value and technical parameters, whilst being responsible for guiding the patient 
through their imaging experience. When several different imaging choices are presented, the 
acceptability of each imaging modality from the patients’ perspective became an intuitive line of 
enquiry for the author, whom has constantly observed the effects that the experience of imaging 
has on people. Patient choice and involvement is integral to modern healthcare (Harding and 
Park 2020: 67) and with new access to sources of information, such as the internet and social 
media, patients and the public are in an excellent position to be well informed of the options that 
may be available to them. This provides an opportunity for patients and the public to collaborate 
with healthcare practitioners and share their individual experiences so that their preferences are 







Until 2014, when the International Myeloma Working Group (IMWG) updated their guidance, the 
gold standard for myeloma imaging was RSS (Minarik et al. 2016: 305), a series of conventional 
x-rays of the major bones in the body. This was the only imaging method available for myeloma 
until the development of whole-body computerised tomography (WB-CT), first reported by 
Horger et al. (2005). The major drawback of early WB-CT was the significant increase in 
ionising radiation that the patients were exposed to compared with RSS. As manufacturers have 
improved the technology of CT scanners, researchers and clinicians have developed methods 
to reduce the dose of ionising radiation for a whole-body CT for the diagnosis of myeloma. This 
improved form of whole-body CT is referred to as low-dose whole-body computed tomography 
(LD-WBCT). Whilst it has been developed and refined over a number of years it has only 
recently started to be widely adopted (Chantry et al. 2017).  
As well as RSS and LD-WBCT, WB-MRI has started to be used for imaging multiple myeloma 
(Messiou and Kaiser 2018: 511). Conventional magnetic resonance imaging (MRI) is usually 
performed on a specific organ or area of the body. Technological advances, alongside the 
development of new MRI scanning parameters that dictate the anatomy and pathology that will 
be demonstrated, led to the initial development of WB-MRI. Steinborn et al. (1999) was amongst 
the first to report its effectiveness at identifying metastases in the skeleton, and Lecouvet et al. 
(1999) explored the possibility of replacing RSS with MRI for staging myeloma. Since this early 
research WB-MRI has been further refined and developed. 
Guidance has been published to assist the clinician with selecting an imaging modality; any of 
them may be used with LD-WBCT or WB-MRI being recommended if available due to their 
greater diagnostic value (Chantry et al. 2017). As with many healthcare services, availability and 





1.3 Thesis Structure and Overview 
Chapter 1 provides an introduction to the topic, the rationale for conducting this study and the 
aims and objectives. 
Chapter 2 is a review of published literature. This begins with a more detailed depiction of 
myeloma and an explanation of the three whole-body imaging techniques that have been 
investigated. Research investigating the diagnostic value of different whole-body imaging 
techniques used in the diagnosis of myeloma, and patient acceptance of imaging is appraised to 
develop an understanding of the research area. 
The first part of Chapter 3 discusses the research methodology and the study design selected. 
Detail regarding the development and review process of the survey instrument is presented 
here. The second part of this chapter reports the methods used.  
Chapter 4 presents the results of the quantitative and qualitative components of the study and 
concludes with a summary of triangulation of the findings. 
Chapter 5 provides a discussion of the implications of the results and findings of the study. 
Additionally, reflections and limitations of the research design are explored. This chapter details 
recommendations based upon the results, and the possible impact of the study. 





1.4 Research Question, Aims and Objectives 
 
What is the perceived acceptability of different whole-body imaging techniques 
experienced by patients being investigated for myeloma? 
 
Aim: To determine the perceived acceptability of different whole-body imaging 
techniques experienced by potential myeloma patients. 
Objective 1: To identify if myeloma patients score a particular whole-body imaging 
modality (RSS, LD-WBCT, WB-MRI) as either being more or less acceptable than its 
counterparts. 
Objective 2: To demonstrate what factors, relating to both the radiology examination and 




2. Literature Review 
2.1 Method and Rationale for the Literature Review  
This chapter will explore and critique the current published literature regarding the use of whole-
body imaging for myeloma, and the patient acceptability and experience of imaging through a 
narrative literature review (Saks & Allsop 2013: 43). Whilst a narrative literature review method 
is limited by its subjectivity, it provides a valuable depiction of the current research and 
knowledge within the subject area and demonstrates the concepts, theories and research 
methods that have guided this study (Bowling 2014: 14; Saks & Allsop 2013: 43). To improve 
the objective quality of the literature review, the included literature has been reviewed with the 
Critical Appraisal Skills Programme (CASP 2019) checklists to ensure it is of sufficient quality 
for inclusion in terms of scientific rigour, the validity of the results and addressing potential bias.  
The first part of this literature review is intended to provide a more detailed depiction of multiple 
myeloma, including the experiences of those living with the condition, to further contextualise 
the study.  
The second part of this literature review includes a detailed description of the whole-body 
imaging methods being investigated and reports upon the published guidance regarding the 
different choices of whole-body imaging available. 
The third part of this literature review is a critical appraisal of research that investigates the 
diagnostic value of the three whole-body imaging techniques. The complexities that prevent a 
consensus on which technique should be primarily utilised are explored.  
The fourth part of the review is concerned with critiquing research that examines patient 
experiences, perceptions or acceptance of whole-body imaging. The purpose of this literature 
review was to provide an understanding of the current issues that affect patient perceptions and 
acceptance of radiological imaging. 
Two separate literature searches were conducted; the first was to identify literature regarding 
the diagnostic value of whole-body imaging used for myeloma, whilst the second concerned the 
patient experience of imaging and living with myeloma. It was not possible to combine these 
searches as attempts to do this did not identify any relevant literature. The inclusion and 
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exclusion terms for the literature searches are available in table 2.1. The results of the literature 
searches are available in appendix 2. 
Table 2.1: Terms used for the literature searches 
Included Terms Excluded Terms 
Radiogr* or Radiolog* or x-ray Radiologist 
CT OR Computed Tomography Teach* 
MRI OR Magnetic Resonance Imaging Education OR Educat* 
Technology AND Imaging Literature prior to 2009 
Multiple Myeloma OR cancer OR oncology PET OR PET-CT OR Positron OR Emission 
Patient AND 
Acceptance OR Experience* OR Perception*  
 
Survey OR Questionnaire  
 
The literature searches were conducted using MEDLINE and CINAHL as these databases 
contain journals that are relevant to medicine, radiology and radiography. Google Scholar was 
used to identify supplementary papers that were not on these databases. Literature from 2009 
onwards was included to account for improvements in imaging technology and to prevent 
attempts at comparing out of date studies with current research (DePoy & Gitlin 2011: 92-93). 
These literature searches yielded a total of 162 papers. Titles and abstracts were reviewed, and 
relevant papers selected for detailed review. To be considered for detailed review selected 
papers were required to compare the effectiveness of two or more whole-body imaging methods 
for the diagnosis of multiple myeloma, or to compare patient perception, acceptance or 
experience of CT, MRI or both types of imaging. These additional criteria ensured selected 
papers were relevant to the topic investigated in this study. The selection process for included 
papers was carried out solely by the author, and is shown in figure 2.1. The PRISMA flow 























Figure 2.1: Flow diagram demonstrating the selection process of papers for the narrative 
literature review 
Initial literature search – titles and abstracts reviewed n = 162 
Studies Excluded n =111 
• Duplicate studies n = 41 
• Not relevant to experiences of CT or MRI n = 58 
• Not relevant to comparing WBI for myeloma n = 12 
Papers retrieved for detailed review n = 51 
Studies Excluded n = 27 
• Primary focus on PET or Pediatric imaging = 10 
• Related to radiotherapy CT = 2 
• Review articles = 6 
• Did not meet CASP criteria = 4 
• Not relevant to CT or MRI = 5 
Studies potentially appropriate for literature review n = 24 
Studies Excluded n = 11 
• Limited relevance to experiences of WBI, CT or MRI 
n = 8 
These studies were used to inform the research 
design and method detailed in chapter 3.2.1 and 
table 3.1 
• Papers relevant to experiences of living with 
myeloma n = 3 
These were used to inform chapter 2.2 
Studies included in narrative review n = 13 
• Studies comparing efficacy of two or more types of WBI for myeloma n = 6 
• Studies investigating experiences of WBI or similar = 7 
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2.2 Multiple Myeloma 
Myeloma is a cancer of the plasma cells found in the bone marrow and is the most common 
primary malignancy of the skeleton. It is estimated that there were approximately 17,600 people 
living with myeloma in the UK in 2010 (Cancer Research UK: 2017) with 5,500 new cases 
diagnosed in the UK each year (Ashcroft et al. 2018: 3). 
The disease starts with the growth of malignant plasma cells in the bone marrow causing an 
increase in osteoclast activity, bone cells that absorb bone tissue, whilst also suppressing 
osteoblasts, the cells responsible for producing new bone tissue (Messiou and Kaiser 2018: 
509). This excessive osteoclastic activity causes the production of abnormal antibodies and 
various cytokines, proteins secreted by the immune system that signal an effect on other cells. 
In myeloma, some of these cytokines encourage the prolific growth of new malignant myeloma 
cells, beginning a cycle of tumour growth, bone destruction and the further production of 
abnormal antibodies (Messiou and Kaiser 2018: 509). The excessive osteoclastic activity also 
leads to areas of bone destruction that can be demonstrated with x-ray, CT and MRI imaging, 
any of which may identify numerous areas of lower bone density, defined as osteolytic lesions. 
No specific cause for myeloma has been identified although age is considered the primary risk 
factor. Myeloma affects the older population with the median age at diagnosis being 70 years in 
the UK (King, Gooding and Ramasamy 2015: 149). Other risk factors are gender, ethnicity, a 
family history of myeloma, autoimmune conditions and obesity (Ashcroft et al. 2016: 5). The 
patient may initially present with any of the following symptoms: fatigue, weight loss, recurrent 
infections, pain, and pathological fractures whilst further investigation may also demonstrate 
anaemia and renal failure (Vlossak and Fitch 2005: 141). Making a differential diagnosis of 
myeloma requires clinical evaluation through a blood test to demonstrate anaemia, 
hypercalcaemia or renal impairment through raised creatinine, alongside a urine test to 
demonstrate the presence of abnormal protein (Field and Clark 2013: 177). The National 
Institute for Health and Care Excellence (NICE 2016: 47) states that further laboratory tests are 
then required to detect and quantify the presence of abnormal plasma cells, or abnormal 
antibodies called paraproteins. The final part of the diagnosis is the identification and evaluation 
of bony lesions through radiological imaging. The confirmation of a diagnosis of myeloma is not 
based upon a single factor but a combination of these clinical features, laboratory tests and 
imaging (NICE 2016: 47).  
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Myeloma is normally preceded by a much more common condition called monoclonal 
gammopathy of undetermined significance (MGUS) whereby paraproteins are present with no 
further symptoms (King, Gooding and Ramasamy 2015: 149). Although not all people with 
MGUS develop myeloma, those who do will require periodic monitoring of their condition. A 
second precursor condition to multiple myeloma, ‘asymptomatic myeloma’, has been described 
by the International Myeloma Working Group (IMWG) as ‘…an intermediate clinical stage 
between MGUS and multiple myeloma in which the risk of progression to malignant disease in 
the first 5 years after diagnosis is much higher…’ (Rajkumar et al. 2014: 538).  
By investigating the specific whole-body imaging techniques used for diagnosing myeloma, the 
unique perspective of those with this condition must also be considered. People living with 
myeloma travel along a continuum of diagnosis and treatment followed by ongoing care with 
periods of remission and recurrence (Hauksdóttir et al. 2016: 75; Nicoletti 2012: 3-4). 
Throughout this journey, there will be frequent hospital visits for diagnostic tests, treatment, and 
follow-up. The impact of myeloma has been recognised by several authors, with Nicoletti (2012: 
3) stressing that the quality of life is as important as extending the patient’s life. Vlossak and 
Fitch (2008: 141) state that although healthcare practitioners cannot presume to know what it is 
like to have a condition as complex as myeloma, they should still attempt to understand its 
impact from the patients’ perspective. A meta-analysis of qualitative research conducted by 
Hauksdóttir et al. (2016: 69) explored the negative effects that a diagnosis of myeloma can have 
on the patients’ psychological and emotional well-being, with concerns regarding changes in the 
bones being cited as a specific source of distress. In interviews with a group of myeloma 
patients, Vlossak and Fitch (2008: 145) found that knowing there will be a definite recurrence of 
their condition, but not knowing when, was one of the most difficult aspects of living with 
myeloma. Although Vlossak and Fitch (2008) found that myeloma patients are usually accepting 
of their required medical interventions, the monthly diagnostic blood tests were a frequent 
source of stress. Participants stated that each new ache and pain reminded them of the 
potential of a relapse. None of the authors investigated the impact that imaging can have on 
those with myeloma, but it may be reasonable to assume that concern over other investigations 
and bone changes could indicate that there is also a burden associated with whole-body 
imaging for bone lesions. All of these authors investigating patients' experiences of myeloma 
identified the need for healthcare staff to provide support in an effort to improve the patient 
experience throughout their care (Hauksdóttir et al. 2016: 77; Nicoletti 2012: 3; Vlossak and 
Fitch 2008: 145). 
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2.3 Whole-Body Imaging Techniques 
As myeloma lesions can be present in any number of the major bones of the skeleton, 
identifying them with radiology requires the use of imaging techniques that do not focus on a 
specific body part but are instead able to obtain images of the majority of the skeleton. These 
techniques are frequently referred to as whole-body imaging. There are four primary imaging 
techniques that can be utilised for whole-body imaging of the skeleton for myeloma; RSS, LD-
WBCT, WB-MRI and positron emission tomography (PET-CT). Guidelines published by NICE 
(2016), IMWG (Rajkumar et al. 2014) and the British Journal of Haematology (BJH) (Chantry et 
al. 2017) recognise that all of these whole-body imaging methods can potentially be used, 
although they each provide recommendations that will be discussed in chapter 2.3.5. It is 
outside the scope of this text to provide an in-depth description of the process of image 
acquisition, but a summary of each technique is provided in chapters 2.3.1, 2.3.2, 2.3.3 and 
2.3.4. 
2.3.1 Radiographic Skeletal Survey (RSS) 
RSS, occasionally referred to as a whole-body x-ray, is an examination that involves performing 
conventional radiographs of the bones of the skeleton that are most likely to be affected by 
myeloma-related osteolytic lesions. The areas that are x-rayed are outlined in table 2.2 with 
different authors describing various RSS protocols that have different numbers of radiographs, 
usually dictated by national guidance and local protocol (Dimopoulos et al. 2009: 2; D’Sa et al 
2007: 53; Lambert et al. 2017: 2491). A skeletal survey uses relatively low doses of ionising 
radiation and takes approximately thirty minutes. It does require some manipulation of the 
patient in order to position them correctly for each radiographic projection which has been 
acknowledged as being potentially painful for some individuals (Dimopoulos et al. 2009: 2; D’Sa 
et al. 2007: 51) although research investigating this has not been found. This imaging technique 
has long been the ‘gold standard’ of whole-body myeloma imaging but has been superseded by 
new techniques that perform better as a diagnostic tool (Minarik et al. 2016: 305). 
An example of the equipment used for RSS and the appearance of osteolytic lesions on the 




Table 2.2: Parts of the skeleton and number of radiographs required for RSS 
 
 Number of Radiographers recommended by different authors. 
Body Part Dimopoulos et al. 
(2009: 2) 
International Review 
D’Sa et al. (2007: 53) 
UK 
Lambert et al. (2017: 
2491) 
Czech Republic 
Skull 1-3 (not specified)* 2 2 
Cervical spine 2-3 (not specified)* 3 2 
Chest and ribs 1 2 2 
Thoracic Spine 2 2 2 
Bilateral humeri 2-4 (not specified)* 4 2 
Forearm Not usually required Not usually required 2 
Lumbar spine 2 2 2 
Pelvis 1 1 1 
Bilateral femora 2-4 (not specified)* 4 2 
Tibia/Lower leg Not usually required Not usually required 2 
Total number of 
radiographs  
≤19 19 19 
 
*Where the author has not specified the number of radiographs for a specific body part the 




Figure 2.2: An example of standard digital radiography x-ray equipment used in the UK 
for RSS.  
 





2.3.2 Low-Dose Whole-Body Computerised Tomography (LD-WBCT) 
Computerised tomography (CT) is a method of cross-sectional imaging whereby an x-ray tube 
and an x-ray detector rotate rapidly around the patient creating an x-ray profile. The x-ray profile 
is then reconstructed into images that represent multiple thin cross-sections of the patient by a 
mathematical iterative image reconstruction algorithm. There are numerous methods of 
conducting CT with the specific clinical question usually dictating the method chosen. Amongst 
the most common method employed is a scan of the thorax, abdomen and pelvis for diagnosing 
a broad range of disorders of the soft tissue organs. Such a scan uses ionising radiation and an 
intravenous injection of contrast agent (Adams et al. 2014: 163).  
Horger et al. (2005) first developed and tested a method of performing a whole-body CT scan 
using a reduced dose of ionising radiation in comparison to a conventional CT scan and without 
the requirement of an intravenous injection of contrast agent for the specific purpose of 
diagnosing myeloma, in lieu of a RSS. This scan is referred to as LD-WBCT and has only 
recently been widely adopted and recommended in place of RSS (Chantry et al. 2017: 381). LD-
WBCT can be performed in less than ten minutes and with minimal physical manipulation of the 
patient in comparison to RSS (Ippolito et al. 2014: 2326). The radiation doses of LD-WBCT 
have been reported as being two to four times greater than RSS (Hillengass et al. 2017: 5) but 
with advances in technology and refinements in the use of LD-WBCT, Lambert et al. (2017: 
2493) have reported equivalent doses of radiation across the two imaging techniques. The 
primary technological advancements have been an increase in the sensitivity of the x-ray 
detector allowing for equivalent quality images with a reduced dose of ionising radiation, 
combined with significantly improved image reconstruction algorithms and modulated 
exposures; a system whereby the CT scanner is able to account for different densities in the 
body and either decrease or increase the required amount of radiation accordingly (Samei & 
Peck 2019: 253-265).  
An example of the equipment used for LD-WBCT and the appearance of osteolytic lesions on 









Figure 2.5: A single CT cross-sectional image through the pelvis at the level of the 
sacroiliac joints. This image demonstrates two osteolytic myeloma lesions. 
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2.3.3 Whole-Body Magnetic Resonance Imaging (WB-MRI) 
Magnetic resonance imaging (MRI) utilises a powerful magnetic field that interacts with the 
combined magnetic fields of the patient's hydrogen atoms. A radio wave at a specific frequency 
is applied to the patient. This causes a phenomenon known as resonance, whereby the 
magnetic fields of the patient's hydrogen atoms synchronise, creating a sum magnetic field that 
can be detected by a device called a radiofrequency receiver coil. The radiofrequency receiver 
coil converts the sum magnetic field emitted by the patient into an electric signal through the 
principle of Faraday’s Law. This signal is processed by the MRI scanner through an image 
reconstruction algorithm that leads to the creation of diagnostic images. The variance in the 
distribution and molecular configuration of hydrogen throughout the body causes the range of 
greyscales on the images that represent different tissue types and pathologies. MRI, like CT, is 
another type of cross-sectional imaging. Multiple sets of images, known as sequences, can be 
obtained that will demonstrate anatomy and pathology differently to build up a complete clinical 
picture. Although there can be variation in WB-MRI protocols, the key sequences required for 
WB-MRI in the diagnosis of myeloma are demonstrated in table 2.3 (Messiou and Kaiser 2018: 
514-516). It should be noted that there is no exposure to ionising radiation associated with WB-
MRI although there are certain contraindications, such as the presence of intracranial clips or a 
pacemaker (Graham, Cloke and Vosper 2011: 294). WB-MRI can take up to one hour (Messiou 
and Kaiser 2018: 515) during which time the patient needs to remain as still as possible. The 
patient will have receiver coils strapped across the head and body and will require some form of 
ear protection as the scan can create sound pressures of up to 120 decibels (Graham, Cloke 
and Vosper 2011: 294). 
An example of the equipment used for WB-MRI and the appearance of myeloma lesions on the 




Table 2.3: WB-MRI sequences required for myeloma imaging 
Type of MRI Sequence and Anatomical 
Plane 
Body part and anatomical plane 
T1 and T2 weighted sagittal images To demonstrate the cervical, thoracic and 
lumbar spines for cord compression or other 
complications caused by destructive myeloma 
lesions 
Dixon sequence in the axial plane Provides both fat and water suppressed 
images from the vertex of the skull to below 
the knee. This sequence demonstrates 
anatomy with good resolution 
Diffusions weighted images (DWI) and 
attenuation diffusion coefficient map (ADC 
map) 
Provides images that are highly sensitive to 









Figure 2.7: Examples of WB-MRI images. The image on the left has been reconstructed in 
the coronal plane and demonstrates anatomy. The diffusion-weighted image (DWI) on the 
right has been reconstructed in the coronal oblique plane and demonstrates myeloma 




2.3.4 Positron Emission Computed Tomography 
Positron emission computed tomography (PET-CT) combines a whole-body CT scan for the 
demonstration of anatomy, with positron emission tomography (PET).  A radiopharmaceutical 
labelled with a positron emitter, usually 18-fluorine-fluoro-deoxyglucose (FDG), is given 
intravenously up to 60 minutes prior to imaging. Areas of increased abnormal metabolic activity, 
such as myeloma bone lesions, absorb a greater amount of the radio-pharmaceutical making 
the scan highly sensitive to pathology (Hansford and Silbermann 2018: 3). This combined 
method of imaging improves both the spatial resolution and the sensitivity of the images 
(Dimopoulos et al. 2009: 6). Although PET-CT can be used for whole-body myeloma imaging, 
the guidelines published by the BJH state that there is insufficient evidence to recommend its 
routine use in cases of newly diagnosed myeloma (Chantry et al. 2017: 385). Furthermore, 
NICE (2016: 79) do not recommend PET-CT for diagnosing suspected myeloma due to financial 
costs, although it may be useful for imaging specific myeloma cases of ‘non-secretory’ myeloma 
or for treatment follow-up. As it is not recommended for routine use in the investigation of 




2.3.5 Published Clinical Guidance 
In 2014 the International Myeloma Working Group (IMWG) updated the criteria for diagnosing 
myeloma in light of technological advances in the diagnostic tools available (Rajkumar et al. 
2014: 542). Previously RSS had been considered the gold standard of whole-body imaging for 
myeloma (Minarik et al. 2016: 305).  The IMWG now recognises the diagnostic value and 
routine use of LD-WBCT and WB-MRI in identifying myeloma-related bone lesions, if these 
modalities are locally available. Although the imaging guidelines published by NICE (2016) and 
the BJH (Chantry et al. 2017) all concur that LD-WBCT or WB-MRI should be used when 
available, they still recognise the use of RSS as an alternative. In the author’s experience, there 
are very few NHS trust in the UK that do not have a CT scanner locally available. The Institute 
of Physics and Engineering in Medicine (IPEM) surveyed 117 of the 183 NHS radiology 
departments and reported a total number of 298 CT scanners (IPEM 2015: 5). A second survey 
of 73 responding NHS radiology departments reported a total number of 171 MRI scanners 
(IPEM 2017: 7). Given that these imaging modalities appear to be largely available and are 
recommended by three expert bodies (Chantry et al. 2017; Rajkumar et al. 2014; NICE 2016) 
the continued use of RSS must be brought into question. 
The published guidance provides recommendations on when to use the different whole-body 
imaging modalities, although the results of laboratory tests, radiology tests and the patient's 
symptoms are all factors that will influence what is primarily the choice of the clinician, alongside 
local availability (Chantry et al. 2017; NICE 2016). This published guidance demonstrates how 
the new whole-body imaging methods are only being routinely employed within the last few 
years. Research that will be discussed in detail in chapter 2.4 has attempted to define the 
efficacy of each test, but both Chantry et al. (2017: 389) and NICE (2016: 85) recognise that the 
patient acceptance of each imaging modality is unknown and may be an outcome of interest in 
future research due to the current focus of patient choice and involvement in healthcare. There 
are failure rates associated with whole-body imaging examinations discussed in chapter 2.4, 
indicating a variance in acceptability that needs to be better understood (Munn et al. 2015). The 
authors own anecdotal experiences of providing whole-body imaging for patients has shown 
that the acceptability of any imaging technique can be unpredictable. Some individuals can find 
a particular examination to be a difficult experience, whilst others may perceive imaging much 




2.4 Review of Research Investigating the Diagnostic Value of Whole-Body 
Imaging for Myeloma 
The primary purpose of imaging is to provide the clinician with the information needed for a 
differential diagnosis to be made. In order to assess the value of any diagnostic test, it needs to 
be compared against a current standard in order to demonstrate whether it is sensitive to 
abnormalities and whether it is able to specify what the abnormalities are. The number of true 
positives and true negatives are also vital when investigating the efficacy of a diagnostic test, 
and the terms sensitivity and specificity are used to refer to this. Although there are a number of 
factors that will influence the choice of a diagnostic test to be used, such as cost and availability, 
sensitivity and specificity remain fundamental to imaging choice. In this chapter, research of the 
diagnostic value of whole-body imaging has been reviewed, with a summary of the papers 
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Regelink et al. (2013) undertook a systematic review to examine whether there is evidence for 
the replacement of RSS in the detection of myeloma lesions with ‘modern imaging techniques’, 
specifically CT, LD-WBCT, WB-MRI or PET-CT. The authors report their search strategy which 
used the Quality Assessment of Diagnostic Studies Criteria (QUADAS) (Whiting et al. 2011) to 
ensure studies of sufficient quality and with full results were included. The thirty-two included 
papers compared two or more imaging modalities against each other. This was done by 
comparing the sensitivity and specificity, as well as the overall number of detected bone lesions. 
This data was subject to a meta-analysis by the authors. Before reviewing the results of this 
study an important limitation needs to be considered; of the 32 studies included only 7 utilised 
whole-body imaging techniques, the results of which have not been reported separately. 
Therefore, these results are mostly demonstrating conventional CT and MRI. Both were shown 
to perform at least equally to RSS in terms of sensitivity and specificity, although the results 
show that there may be lesions detected by RSS that are not shown on the other imaging 
modalities. However, when reviewing the overall detection rate of bone lesions, the authors 
reported that CT and MRI detected up to 80% more lesions than RSS (Regelink et al. 2013: 55). 
While RSS was shown to be the inferior imaging method, if the lower detection rate of RSS 
doesn’t affect the accuracy of an individual's diagnosis or the staging of disease then it may be 
possible to justify using RSS when it is the only imaging modality available. As outlined in 
chapter 2.3.5, the surveys conducted by IPEM (2015: 5; 2017: 7) indicated good availability of 
both MRI and CT scanners in the UK. 
Regelink et al. (2013: 55) report that most of the CT scans included in the meta-analysis were 
low dose with two studies using a higher radiation dose. The details provided are insufficient to 
allow the reader to interpret the radiation doses used for each study. This introduces a 
significant bias as it is a known scientific principle that radiation dose has a strong impact on 
image quality which will in turn influence diagnostic value (Samei & Peck 2019: 212-213). As 
radiation dose is a key variable that effects image quality, this introduces further heterogeneity 
to the included studies, hampering direct comparison. Another variable that should be 
considered when interpreting the results is maturation; the effect that time can have on the 
validity of the research (DePoy & Gitlin 2011: 92-93). In this meta-analysis research from 1985 
to 2012 was included. Over this period changes in practice and improvements in technology will 




Whilst the meta-analysis by Regelink et al. (2013) highlights the value of WB-CT and WB-MRI it 
also demonstrates to the reader the barriers in attempting to compare multiple studies. This 
issue has also been recognised by NICE (2016: 66, 84) who stated that the studies included to 
provide evidence for their myeloma guidelines suffered from considerable heterogeneity in 
estimating sensitivity and specificity, and the quality of the evidence was moderate to low when 
assessed with QUADAS criteria (Whiting et al. 2011). There have been a number of studies 
published since 2013 that continue to investigate the diagnostic value of different whole-body 
imaging techniques for myeloma.  
Wolf et al. (2014) researched the sensitivity of RSS in identifying myeloma lesions, against 
either LD-WBCT or WB-MRI. The study was conducted retrospectively, with data collected from 
52 patients who had RSS and LD-WBCT, and 119 patients who had RSS and WB-MRI. The 
images collected were evaluated by two radiologists to identify the size, location and number of 
bone lesions demonstrated. To eliminate bias through prior knowledge, the radiologists were 
blinded to the participants' findings on different scans. In addition, having two radiologists review 
the images eliminated objectivity with Wolf et al. (2014: 1224) reporting that the radiologists 
were in consensus across all of the images. Wolf et al. (2014: 1224) also provided detailed 
information regarding the parameters used for LD-WBCT and WB-MRI, in addition to the mean 
radiation dose. As demonstrated in the meta-analysis by Regelink et al. (2013), different 
scanning parameters potentially add a number of variables to the imaging technique and effect 
heterogeneity. By providing these parameters the reader can consider their effect on the study, 
and sufficient detail has been provided to allow the reader to replicate this imaging. The mean 
radiation dose for LD-WBCT was reported to be in the range of 9.4 and 11.3 mSv compared to 
a mean radiation dose of 2.4 mSv for RSS.  
Wolf et al. (2014: 1225-1226) report that RSS identified bone lesions in 30 of the 52 patients 
whilst LD-WBCT identified bone lesions in 42 patients. Through statistical analysis a significant 
difference in detection was demonstrated between these imaging modalities. Additionally, there 
were no lesions visible on RSS that could not also be identified on LD-WBCT. In the second 
group of 119 patients, WB-MRI detected lesions in 43 patients, whilst RSS only detected lesions 
in 19 patients. Again, this difference in detection rate was shown to be statistically significant 
(Wolf et al. 2014: 1226). The effect of this improvement in lesion detection is that some patients 
being investigated for myeloma would have had have their disease up-staged, potentially 
leading to treatment that they would not have received had they only been investigated using 
RSS. 8 of the 52 patients who had WB-CT could have received treatment that they would not 
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have had if they had only received RSS, as this would have staged them as having MGUS (Wolf 
et al. 2014: 1227). For the group of 119 patients that received WB-MRI and RSS, the WB-MRI 
would upstage 38 patients, but even more significantly, down-stage 45 patients potentially 
preventing unnecessary treatment in 8 of these (Wolf et al. 2014: 1228). These changes in 
staging have been retrospectively applied to illustrate the impact of improved diagnostic value 
and do not reflect the clinical decisions made for any of the patients. They illustrate the 
importance utilising the most accurate imaging technique to ensure patients are staged 
accurately and then provided with the appropriate treatment.  
The WB-CT performed in this study is reported as being low dose, although the authors 
recognise that the mean dose of 9.4-11.3 mSv is higher than other reported LD-WBCT doses of 
4.1-7.5 mSv of radiation (Wolf et al. 2014: 1229). Although there is a recognised relationship 
between radiation dose and image quality (Samei & Peck 2019: 212-213) Wolf et al. (2014: 
1229) argue that a low-dose CT protocol should not affect the diagnostic accuracy in the 
detection of osteolytic lesions. This is a valid argument as a reduction in radiation will have the 
most impact on the image quality of soft-tissue structures, which are outside the scope of a WB-
CT examination for diagnosing myeloma, and the image quality of boney structure will be much 
less effected. 
This study demonstrates how whole-body imaging with greater sensitivity can affect the staging 
and treatment for myeloma patients. Wolf et al. (2014: 1230) also consider patient comfort of 
RSS and LD-WBCT, stating that the latter may be a more comfortable examination for the 
participant due to the quick examination time and the minimal positioning requirement, although 
they do not discuss the comfort of WB-MRI. The conclusion of this study is that LD-WBCT 
should be utilised over RSS for all cases of myeloma. For patients with MGUS, LD-WBCT 
should not be used if WB-MRI results are normal. This is because those with MGUS will not 
necessarily develop into myeloma and the risks of exposure to radiation must be considered.  
The results presented by Wolf et al. (2014) do little to support the ongoing use of RSS. The 
evidence provided indicates that incorrectly staging disease could lead to either unnecessary 
treatment, or treatment not being given when it could be of benefit. Despite the evidence 




A limitation recognised by the Wolf et al. (2014) is that it was not possible to compare WB-MRI 
and LD-WBCT against each other as only two participants in the cohort had undergone both 
imaging modalities. Due to the ethical considerations of exposing patients that are also research 
participants to additional ionising radiation, comparing different scan types is normally only 
possible when imaging is part of the patient’s clinical care, or if the study uses a prospective 
design. 
Minarik et al. (2016: 305) conducted a prospective comparison of RSS, LD-WBCT and WB-MRI 
across 112 participants, the rationale being that RSS may underestimate myeloma-related bone 
disease. All three whole-body imaging techniques were performed on 43 participants allowing 
for direct comparison of the number of detected bone lesions. 83 participants were known to 
have multiple myeloma, and 28 had a diagnosis of MGUS. Minarik et al. (2016: 306) provide 
demographic data that demonstrates the characteristics of the cohort are representative of the 
Caucasian population living with monoclonal gammopathies. 
The technical parameters of RSS and LD-WBCT are described in moderate detail with the 
mean dose of radiation for LD-WBCT reported as being 4 mSv. Specific information regarding 
the WB-MRI parameters is lacking, therefore the reader is unable to make any judgement on 
the scanning parameters selected, and if those recommended by Messiou and Kaiser (2018: 
515) for detecting myeloma have been included. A single radiologist was designated to review 
all of the LD-WBCT scans, with a second radiologist reviewing the WB-MRI in order to prevent 
bias due to knowledge of the patient's results on the other imaging technique. Whilst this is an 
excellent method to eliminate variables, it is unclear how the RSS was reviewed, and if the 
reviewers were blinded to these results or not. 
The presented results are descriptive with percentages provided for the number of detected 
lesions on each modality; no statistical analysis was performed. The authors have separated the 
results to show the sensitivity of the different whole-body imaging techniques for different parts 
of the body, primarily the skull, spine and long bones. Regarding the skull, LD-WBCT identified 
myeloma lesions in 16% of patients that had a negative result using RSS. WB-MRI was unable 
to identify any of the skull lesions. In identifying lesions of the spine, WB-MRI demonstrated 
lesions in 4 of the patients (23%) that had no lesions demonstrated on LD-WBCT, although the 
authors state that this would not have affected the staging for these patients. Minarik et al. 
(2016: 306-307) state that as a result of WB-MRI and LD-WBCT, one patient who had a 
diagnosis of MGUS through RSS was upstaged to multiple myeloma. Throughout the rest of the 
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skeleton, all three imaging techniques were largely in concordance regarding the number of 
bone lesions although LD-WBCT and WB-MRI identified additional lesions in 15% of the 
patients (Minarik et al. 2016: 307). 
Whilst this research utilised a small sample, myeloma is uncommon, and it was able to collect 
data prospectively. It has been included in this literature review as the study was able to do 
comparisons across all three whole-body imaging techniques, although the patients that had 
received all three imaging techniques are not reported separately. The results, although 
descriptive, highlight to the reader a further variable in identifying bone lesions; the location 
within the skeleton. Minarik et al. (2016: 307) state that as a result of this study, 4 MGUS 
patients had bone lesions identified using LD-WBCT. Although the lesions were not significant 
enough to up-stage the patients to multiple myeloma, they will be carefully monitored. Minarik et 
al. (2016: 308) conclude that RSS may give false-negative results and underestimate bone 
lesions. While WB-MRI performed better in identifying spinal lesions, the additional costs should 
be considered. The authors recommend either WB-MRI supported by X-ray of the skull or LD-
WBCT supported by MRI of the spine. 
The evidence presented by Minarik et al. (2016) does provide some support for the use of RSS 
for imaging of the skull and long bones of the skeleton, but caution must be taken as under-
staging disease through the use of RSS is possible. The issue of cost is addressed, and while 
the effective use of resources is important for maintaining a sustainable health service, the 
guidelines on the diagnosis and management of myeloma produced by NICE (2016: 74-78) for 
the NHS argue that a more expensive imaging modality has the potential for long term savings. 
The estimated cost of RSS is £108.82, LD-WBCT is £147.17 and WB-MRI is £203.06. The 
NICE (2016) guidelines conclude that there is a strong case that using LD-WBCT or WB-MRI is 
cost-effective due to the benefits of early detection and negating the need for additional more 
detailed imaging if RSS demonstrates bone lesions. Therefore, if the cost of imaging is not the 
reason that RSS is sometimes selected over other whole-body imaging modalities, availability 
must be considered as an influencing factor. 
Two further studies have provided a detailed analysis of the diagnostic value of RSS and LD-
WBCT, whilst also considering the associated dose of ionising radiation and the location of 
lesions in the skeleton. Lambert et al. (2017) performed RSS and LD-WBCT on a group of 74 
patients, giving a total of 486 separate anatomical regions. Images were reviewed by two 
observers to ensure consensus, and statistical analysis was performed using the Wilcoxon 
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signed-rank test or pairwise t-test. RSS identified bone disease in 127 of 486 anatomical 
regions, and these findings were compared to LD-WBCT. RSS gave false-negative results in 
16% of patients and gave false-positive results in a further 8%. Lambert et al. (2017: 2492-
2493) were also able to demonstrate that RSS was significantly less sensitive at identifying 
bone lesions in the spine, ribcage and scapulae, supporting the descriptive study conducted by 
Minarik et al. (2016). Lambert et al. (2017: 2493) argue that the overall lack of sensitivity of RSS 
is mitigated by good sensitivity in the long bones. However, this study reported that LD-WBCT 
adjusted the staging for 24% of the study participants when compared to staging made using 
only RSS (Lambert et al. 2017: 2493). As stated previously, adjusting the staging of myeloma 
has the potential to influence treatment decisions and therefore the use of LD-WBCT over RSS 
has to be recommended. 
Lambert et al. (2017: 2492) provide accurate data regarding the comparative dose of ionising 
radiation with RSS being reported as having a mean dose of 2.5 mSv and LD-WBCT of 2.7mSv, 
showing the reader how effective LD-WBCT can be at an equivalent dose. This dose is 
comparable to the ionising radiation doses reported in an audit at the author’s workplace of 2.45 
mSv (Wayte 2020), although the mean dose of RSS at the author’s workplace has not been 
audited. Both of these mean doses are significantly lower than the mean dose of 9.4-11.3 mSv 
reported by Wolf et al. (2014: 1227). A number of possibilities exist that could account for the 
difference, most notably improvements in technique and equipment over time are likely to push 
doses down. These figures serve to demonstrate that it is possible to get the dose of ionising 
radiation for LD-WBCT to be comparable to that of RSS, which would further support the 
argument for using LD-WBCT. However, if an imaging modality exists the requires no exposure 
to ionising radiation then it becomes possible to completely mitigate the associated risks. 
Therefore, the reason for the continued use of all three modalities is likely to return to the issue 
of resources and the availability of whole-body imaging equipment and expertise. 
Research by Hillengass et al. (2017) collected retrospective data from 212 participants who had 
received RSS and LD-WBCT across eight sites worldwide. Detailed information is provided 
regarding the imaging techniques used and associated radiation doses. Images were reviewed 
for consensus by three blinded observers. Of the 212 participants, LD-WBCT identified bone 
disease not demonstrated on RSS for 54 patients. Conversely, RSS was able to identify bone 
disease in 12 patients that was not seen using LD-WBCT, providing further evidence that there 
may not be a single whole-body imaging technique that will always reliably identify myeloma 
lesions. The findings of this study further support the research conducted by Minarik et al. 
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(2016) and Lambert et al. (2017) with LD-WBCT demonstrating significantly higher detection 
rates of myeloma lesions in the spine and ribcage (Hillengass et al. 2017: 3).  
In a valuable sub-group analysis, Hillengass et al. (2017: 3-4) compared the prognostic value of 
RSS and LD-WBCT for both multiple myeloma patients and asymptomatic myeloma patients. 
They concluded that there was no significant prognostic difference in identifying additional 
lesions using LD-WBCT but agreed with Minarik et al. (2016) that identifying additional lesions 
can demonstrate if an asymptomatic myeloma patient has a greater risk of progressing to 
multiple myeloma (Hillengass et al. 2017: 5). They state a concern of identifying myeloma 
lesions earlier is that the potential exists for beginning treatment at a time when it is not yet 
necessary but leading to potential side effects and complications for patients (Hillengass et al. 
2017: 4). Although this concern may exist, in the NHS each patient would be treated on an 
individual basis; the results of imaging would be reviewed alongside other laboratory testing by 
a Haematology Consultant with further input from a multidisciplinary team meeting before 
treatment decisions are made. 
Hillengass et al (2017: 5) recommend LD-WBCT over RSS. Although they have not reported a 
mean dose of radiation, they believe the radiation dose of LD-WBCT to be between 2 - 4 times 
greater than that of RSS but argue that LD-WBCT is faster and more convenient for the 
patients. 
A summary of the research that has been reviewed is presented in table 2.4. These studies 
share a common theme; identifying an imaging modality that always outperforms its 
counterparts is not possible due to the largely unpredictable nature of the sites of bone disease 
and the additional variables introduced through different scanning techniques and doses of 
ionising radiation. Whilst some research has demonstrated that more accurate scanning can 
alter the staging of a patients’ disease, other authors have warned of the possibility of starting 
treatment when it may not yet be necessary through over staging (Wolf et al. 2014: 1227-1228; 
Hillengass et al. 2017: 4). However, if cost effective technology exists to obtain the most 
accurate diagnostic information, not utilising it to its fullest extent seems irresponsible, 
especially when the diagnosis and treatment decisions are supported by a number of other tests 




All of the research reviewed here shares a second consensus; RSS is not recommended over 
its counterparts. In spite of this evidence it is still used in the UK when other imaging techniques 
are unavailable, and no researchers or professional bodies have recommended that the use of 
RSS be completely discontinued, but instead recommend the use of other imaging modalities 
whenever possible. Availability of LD-WBCT and WB-MRI has been explored as a possible 
barrier to its more frequent use, as well as the dose of ionising radiation associated with LD-
WBCT. However, this literature review has shown how the radiation dose of LD-WBCT can be 
comparable to RSS and does not need to exceed a factor greater than 2. Reviewing these 
imaging techniques from a technical and medical perspective has not provided a definitive 
consensus regarding the best imaging choice. For the author, the logical step is to consider the 
imaging techniques from the perspective of the service users. Some of the research detailed 
above briefly mention the differences of whole-body imaging from a patient perspective, in terms 
of the comfort and length of examination and whether manipulation of the patient is required 
(Wolf et al 2014: 1230). However, it is outside the scope of these studies to investigate this in 




2.5 Review of Research Investigating Patient Experiences of Radiological Imaging 
The experience of undergoing some form of imaging to investigate myeloma should not be 
taken for granted and could have a serious and unpredictable impact on the patient. By 
investigating and understanding the impact that imaging has on the myeloma patient group, 
healthcare practitioners can be better equipped to improve the experience and acceptability of 
whole-body imaging. Research specific to patient perceptions and acceptance of the whole-
body imaging methods unique to myeloma was difficult to find, especially for LD-WBCT and 
RSS where no published literature has been uncovered. However, there is research 
investigating WB-MRI and CT in more general terms that will be reviewed here and considered 
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Murphy (2001: 195) conducted interviews with 26 patients who had experienced either 
conventional CT or MRI scans to better understand how the patient responds to high technology 
imaging from a human perspective. As demonstrated throughout chapter 2.4, this interaction is 
often overlooked in favour of assessing imaging technology from the perspective of functionality 
and technical details (Evans et al. 2018: 1). The research conducted by Murphy (2001: 193-194) 
demonstrated the potential for modern imaging technology to induce fear or anxiety which can 
lead to depersonalisation and other emotional burdens. Many reasons for this are explored by 
Murphy (2001: 194, 197-199) with claustrophobia, poor preparation and knowledge prior to 
imaging, and the separation of the patient and the healthcare practitioner all being cited. 
Although manufacturers frequently try to improve the patient experience by advances in 
hardware, such as increasing the amount of space in a scanner, there is still a real potential for 
radiological imaging to propagate a psychological and physical burden (Munn and Jordan 2011: 
326). It is the experience of the author that in busy NHS radiology departments, the efficient 
acquisition of images and throughput of patients is sometimes prioritised over the care of 
individuals, leading to a negative experience (Harding and Park 2020: 62). This is supported by 
a qualitative systematic review of 15 studies investigating patients’ interactions with imaging 
technology conducted by Munn and Jordan (2011: 324, 330). They identified staff support as 
being an important part of ensuring that a patients’ interaction with imaging technology is a 
positive one, and also commented on the significant impact healthcare staff have on the patient 
experience, both positive and negative. Additionally, people undergoing imaging feel a need for 
information which they may obtain from a number of sources, both credible and non-credible 
(Munn and Jordan 2011: 326). The information provided and the method of delivery will form 
part of the patient experience and should be considered throughout. 
One of the first studies investigating the patient experience of WB-MRI was carried out by 
Adams et al. (2014: 163) at a time when the use of WB-MRI was just starting to enter clinical 
practice. They performed a comparison of the experiences of 36 lymphoma patients having both 
WB-MRI and CT using questionnaires with four-point Likert scales. Adams et al. (2014) did not 
report upon how the questionnaire was developed and tested, therefore its validity is unknown. 
The median scores regarding the concepts ‘worry prior to the examination’ and ‘experience of 
the examination overall’ showed that WB-MRI scored lower than CT, with median scores of 1 
and 2 respectively on a four-point Likert scale (where 1 is attributed to ‘no worry’ or a ‘not 
unpleasant experience). This indicates that patients' experiences of WB-MRI were superior to 
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CT and confirmed as being statistically significant through analysis using the Wilcoxon signed-
rank test, even with a limited sample size. It must be taken into account that this study is 
investigating a conventional CT scan which utilises an intravenous injection of contrast agent 
that has some potential associated risks, and the oral consumption of a second contrast agent; 
WB-MRI usually requires neither of these. Adams et al. (2014: 166) conclude that these contrast 
agents may cause additional patient burden  and must be considered when interpreting these 
results. The contrast agents consumed for CT are anecdotally considered to be unpleasant and 
can also increase the amount of time a patient has to spend within a radiology department by 
one hour. It is for these reasons, in addition to the cost, that oral contrast agents are no longer 
routinely used in the NHS.  
The evidence presented by Adams et al. (2014) contradicts a usually accepted norm that MRI is 
difficult to tolerate due to the length of the scan and the perception of claustrophobia (Heyer et 
al. 2015; Munn et al. 2015; Tugwell-Allsup & Pritchard 2018). Munn et al. (2015: 60) carried out 
a meta-analysis of 18 international studies that investigated claustrophobia in the MRI 
environment. They reported MRI failure rates due to claustrophobia as being between 0.46% to 
5.29%. None of the studies included WB-MRI examinations which tend to be longer than many 
standard MRI scans (Adams et al. 2014: 163). Although it may seem reasonable to infer that a 
WB-MRI for myeloma is more difficult to tolerate that other forms of MRI, there are too many 
intrinsic and extrinsic variables to control for to reliably draw this conclusion. Examples of such 
variables include the age and design of an MRI system, as more modern systems allow more 
space, an individual's willingness to complete an examination in spite of negative feelings 
towards MRI, or the use of sedatives. Munn et al. (2015) recognise the limitations of the meta-
analysis due to heterogeneity of included studies. Additionally, those patients who manage to 
complete an MRI scan, despite experiencing severe claustrophobia or anxiety, are not 
accounted for. This study still reinforces the idea that MRI can be difficult to tolerate for a small, 
but significant, percentage of people. As this was a meta-analysis of the prevalence of 
claustrophobia no data is presented regarding the patient perceptions of MRI. 
Recognising that the psychological burden of MRI is well researched, Heyer et al. (2015: 109) 
conducted a study to measure whether there is a psychological burden related to CT. 852 
patients who had undergone a CT scan over a 9 month period completed the state-trait anxiety 
inventory (STAI) questionnaire, a validated tool for measuring anxiety in a range of settings. In 
addition to the included 20 questions, the authors added 10 additional questions that were 
specific to the experiences of radiology. Like the research conducted by Adams et al. (2014), 
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this study investigated conventional CT that may include the administration of intravenous and 
oral contrast agents. Heyer et al. (2015: 107) reported 260 patients were given intravenous 
contrast, indicating to the reader that the remaining 592 would have experienced a CT scan 
without contrast, similar to the experience of WB-CT. The collated anxiety scores demonstrated 
that patients can experience anxiety prior to CT, and the STAI scores are comparable with the 
anxiety experienced before MRI reported in other research (Heyer et al. 2015: 111). It should be 
noted that the MRI systems employed in older research may be quite different to the MRI 
scanners of recent years, making a direct comparison of experiences difficult. Due to advances 
in imaging technology newer MRI systems are quieter, more spacious and potentially quicker 
(Munn et al. 2015: 62). Heyer et al. (2015: 108) note that patients who had never previously 
experienced a CT scan or required the administration of contrast gave higher anxiety scores. 
Regarding the use of ionising radiation, only 354 (41.5%) of the cohort stated they felt no 
anxiety due to radiation and 166 (19.5%) of participants indicated that the exposure to ionising 
radiation was a moderate or high cause of anxiety (Heyer et al. 2015: 109). People's 
understanding of radiation and its associated risks and effects varies greatly. Understandably 
Heyer et al. (2015) have not been able to account for each individual's knowledge in the results, 
but it still indicates radiation is an additional burden of CT that is not present in MRI. Heyer et al. 
(2015: 111) conclude that imaging associated anxiety does not only occur prior to MRI but is an 
equal problem in CT and should be taken seriously. 
This research utilised a large sample and a validated questionnaire, demonstrating a rigorous 
method. The evidence presents a CT experience that would be similar to LD-WBCT allowing for 
transferability of the findings to those living with myeloma. Although the results were obtained 
outside of the NHS, the findings serve to highlight the potential burden of all forms of CT, an 
examination which is commonplace within the NHS, but its burden is frequently overlooked.  
Evans et al. (2017) interviewed 51 patients who had received both WB-MRI and conventional 
CT for the staging of either colorectal or lung cancer. The purpose of this qualitative study was 
to investigate the patient experience of WB-MRI and compare this with conventional CT and 
PET-CT to determine if cancer patients are accepting of WB-MRI and whether there are 
associated burdens, in addition to living with cancer (Evans et al. 2017: 1-2). The authors chose 
one-to-one interviews to capture a rich description of experience whilst not requiring any prior 
knowledge of potential responses (Evans et al. 2017: 2). Thematic analysis demonstrated that 
WB-MRI was perceived to be more challenging than other imaging techniques. The key themes 
identified were claustrophobia, physical discomfort, noise and the duration of the scan. These 
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themes are to be expected as they are well-documented concerns patients have during MRI. A 
theme of interest to emerge related to patients considering the scan in the context of their own 
condition, with individuals contemplating the implications the scan results may have on their 
own care and treatment. This finding is parallel to the findings by Vlossak and Fitch (2008: 145) 
discussed in chapter 2.2; knowing that there will eventually be a recurrence of disease is 
amongst the most difficult aspects of living with myeloma.  
A second interesting theme that many participants discussed related to prior experience of MR. 
Although few participants had experienced MRI in the past, the experience was stated as being 
of benefit. Some of those that had no prior experience of MRI had discussed the imaging 
technique with friends and family who had undergone the scan. This vicarious experience was 
perceived as both positive and negative, depending on the experiences of the third party, but 
ultimately had little impact on the participants own experiences (Evans et al. 2017: 6). It does 
illustrate how patients seek out information prior to imaging, a finding also reported by Munn 
and Jordan (2011: 326). Of the 51 participants, four were unable to complete the WB-MRI but 
all participants stated that they would be prepared to undergo WB-MRI again if recommended 
by their clinician, although the authors note that, ‘...this agreement was offered with varying 
enthusiasm’ (Evans et al. 2017: 7).  
The authors conclude by noting the broad range of experiences that they documented, and 
whilst particular co-morbidities can make WB-MRI more challenging, there were still unexpected 
situations whereby a participant who felt unable to undergo the scan managed to tolerate the 
whole scan, whilst another person unexpectedly found the process difficult. This reinforces the 
importance of understanding individual experiences; whilst healthcare practitioners shouldn’t 
presume to understand what it is like to undergo imaging for cancer, efforts to understand the 
patient perspective are integral in ensuring staff can better support the service user. Evans et al. 
(2017: 8) identified communication and support from staff as having the potential to improve the 
patient experience, as participants reported a variety of differing staff interactions that all had a 
significant impact on the overall experience. 
In a second concurrent study by the same group of authors, 115 oncology patients completed 
questionnaires concerning their experiences of WB-MRI against other imaging methods in an 
effort to identify predictors of reduced patient tolerance (Evans et al. 2018: 2). The survey tool 
used has been adapted from a validated tool created by Salmon et al. (1994) and utilises 26 
questions per imaging modality with 7 point Likert scales, in addition to collecting detailed 
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demographic data (Evans et al. 2018: 4). Given the length of this survey the possibility of 
questionnaire fatigue should be a consideration (Bryman 2016: 225-226; Hulley et al. 2013: 
231). Nevertheless, the authors were able to meet their recruitment target dictated by a power 
calculation for the related t-test, assuming a medium effect size (d=0.5), α error probability (p = 
0.05), and 95% power. A participant incentive was offered (Evans et al. 2018: 2). 
Statistical analysis of the results using the Wilcoxon sign test demonstrated that WB-MRI was 
perceived to be less acceptable than conventional CT or PET-CT, with 84 participants (77.8%) 
stating that CT/PET-CT was very acceptable versus only 73 participants (65.2%) finding WB-
MRI to be very acceptable. Despite this result, the scores for each imaging technique ‘not being 
at all acceptable’ were the same, with only one participant (0.9%) recording this response for 
both imaging techniques. This indicates that while acceptability may be lower for WB-MRI, it is 
tolerated just as well as CT or PET-CT. The results from both studies by Evans et al. (2017; 
2018) contradicts the data presented by Adams et al. (2014) in that WB-MRI is less acceptable 
than other imaging techniques. Evans et al. (2018: 7) argue that a reason for the disparity in the 
two studies is due to the use of intravenous contrast agent with WB-MRI in their study which 
has been identified as being a burden to the patient (Adams et al. 2014: 166); contrast was not 
used in the research by Adams et al. (2014). It may be inappropriate to apply the findings 
reported by Evans et al. (2018) to the myeloma group as they would not require an injection of 
contrast agent as part of an imaging examination for myeloma lesions. A second additional 
burden that is not considered by Evans et al. (2018) is the use of ionising radiation which has 
been identified as a potential additional burden for patients undergoing any form of CT (Heyer et 
al. 2015:109-110). The two studies were reported four years apart. Although this is a relatively 
short period of time in terms of imaging technology development it still remains a variable. 
Evans et al. (2018) compared participant scores of acceptability with demographic data and 
found the statistically significant predictors of reduced patient tolerance were co-morbidities and 
psychological distress, both of which would potentially impact the myeloma group (Vlossak and 
Fitch 2008; Nicoletti 2012). The authors conclude that patients undergoing a WB-MRI who have 
these predicting factors may benefit from additional support. 
A limitation of the two studies by Evans et al. (2017: 8; 2018) is that participants who have 
refused a whole-body MRI are not represented within the sampling frame. Learning why some 
people refuse WB-MRI may provide useful insight. A second limitation is that both of these 
studies group PET-CT and conventional CT as a single entity. There are some fundamental 
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differences between these imaging modalities and the appropriateness of reporting the results 
together must be questioned. Although considering the rigour of the survey tool and large 
sample size of the research conducted by Evans et al. (2017; 2018) the results cannot be 
overlooked, especially as they are corroborated by two methodologies. 
Oliveri et al. (2018) conducted a survey study of oncology patients undergoing WB-MRI, similar 
to the research by Evans et al. (2018). Oliveri et al. (2018: 246) argue that as WB-MRI does not 
use radiation and can be performed without intravenous contrast it should be the preferred 
imaging option for service users, although the issue of cost and availability has not been 
considered. The aim of this study was to investigate the perceptions and acceptance of WB-
MRI. The survey instrument was based on a survey devised by Schönenberger et al. (2007) 
containing 18 questions with responses mostly recorded using Likert scales. This was 
administered to the participants both before and after their WB-MRI. 70% of the cohort of 135 
patients had experienced some other form of whole-body imaging in the past and 63% of 
participants reported some concern prior to the examination, although 67% of this group stated 
their main concern was the outcome of the scan, a variable that is impossible to control for 
(Oliveri et al. 2018: 248). 
Regarding discomfort of WB-MRI, 51.9% of patients reported no discomfort, 44.2% experienced 
slight or moderate discomfort with the small remainder experiencing strong discomfort. Overall 
>81% of patients recorded a high or very high degree of satisfaction with WB-MRI, with <1% 
reporting low overall satisfaction. These results indicate a good level of acceptability for WB-
MRI, which is further supported by 69% of patients stating that WB-MRI was more acceptable 
than other forms of imaging they had experienced, although no reasons are provided for this. 
Pearson correlation tests demonstrated that patients with high anxiety prior to the scan and 
feelings of discomfort after the scan demonstrated a significant correlation (Oliveri et al. 2019: 
248-249). A statistically significant correlation using a χ2 test was reported between patients 
being provided with information prior to WB-MRI and high global satisfaction. Patients were 
briefed by a radiologist before their WB-MRI. This would not be standard practice in the UK and 
may introduce a bias to the results by influencing the participants’ perceived acceptability of 
WB-MRI that does not reflect standard practice. Prior to the scan 80% of participants felt that 
they were given good or very good information, which may be evidence of this (Oliveri et al. 
2018: 248). DePoy and Gitlin (2011: 93) describe a threat to the external validity of research 
called reactivity, whereby participants are responding to being part of the study, unwittingly 
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influencing the results. Without knowing whether the researchers took steps to account for 
reactivity, its bias has to be taken into account when interpreting the results. Reactivity could 
potentially influence any of the prospective studies discussed in this literature review where 
patients received imaging as part of a research project. Whilst the transferability of this finding is 
questionable, it once again highlights the benefits of providing information. It could be inferred 
that the quality of the information provided by the radiologists was the reason for such high 
satisfaction for an examination that is widely understood to be challenging. 
Oliveri et al. (2018: 249) report a further possible bias; the majority of the cohort had some 
previous experience of MRI, although unfortunately the exact number is not provided. Similar to 
the research conducted by Evans et al. (2018), Oliveri et al. (2018) have grouped all of the other 
whole-body imaging techniques together. Reporting them separately may have been more 
useful in investigating the differences between these techniques. Due to these limitations, it 
would be difficult to apply the findings of this study to the NHS setting although the study 
successfully highlights the importance of being provided with information to improve the 
acceptability of whole-body imaging and to mitigate pre-scan anxiety. A second theme that 
Oliveri et al. (2018: 249) were able to illustrate was the positive effect that a previous experience 
of whole-body imaging can have acceptability, which supports the research by Heyer et al. 
(2015: 111). 
The research examined throughout the second part of this literature review, summarised in table 
2.5, has demonstrated the variables that influence patients experiences and acceptability of 
whole-body imaging. Key themes are patient anxiety, comorbidities, staff support, and the 
information provided. These are in addition to the varying physical aspects of the different 
imaging techniques, such as time, radiation and a ‘claustrophobic’ environment. The burden of 
MRI for those undergoing such an examination is well documented and investigated. Of interest 
is the additional research that investigates the burden of a CT scan. The experience of the 
author is that this is frequently overlooked as CT scans are performed with increasing regularity 
in the UK and are perceived as routine by some healthcare professionals, although this 
perception may not be true for the patients. Uncovering some of the burdens of MRI and CT 
leads the author to consider if there may be any associated burdens with a conventional x-ray or 
RSS that have not been investigated or documented, as no research on acceptance or 
experience of RSS was uncovered. A second point for consideration is whether some of the 
burdens of having an MRI scan still apply, as Adams et al. (2014) and Oliveri et al. (2018) report 
WB-MRI as being not only well tolerated, but universally preferred to other imaging. Whether 
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this is due to advances and improvements in MRI equipment and techniques, or as a result of 
the study designs is difficult to say with certainty. 
It is unsurprising that much of the research investigating the acceptance and perception of 
imaging techniques has focused on oncology patients, as this group frequently requires 
radiological imaging for diagnosis and staging. The imaging options for myeloma are unique to 
that patient group; this may account for the lack of research examining perceptions or 
acceptance of RSS or LD-WBCT.  
As three fundamentally different whole-body imaging modalities exist for myeloma, an 
opportunity is provided to investigate and compare the acceptability and patient perceptions of 
these imaging modalities. In doing so it may be possible to demonstrate if there is a whole-body 
imaging technique that is preferred by those living with myeloma, which can be used to inform 
future imaging pathways and referral guidelines. Secondly, it will allow those who have 
experienced myeloma to share their stories in order that radiographers and clinicians can further 
understand the psychological and physical burden of imaging and explore opportunities for 
reducing this burden. Research investigating the patient acceptability of imaging is an excellent 
method of educating healthcare practitioners regarding patient perceptions and implementing 




3. Methodology, Design and Method 
3.1 Methodology 
A pragmatic mixed methodology combining aspects of the positivist and interpretivist paradigms 
was used to design this study and address both of the study objectives. The epistemological 
view of positivism is that a single reality exists which can be objectively understood through 
observation and measurement (DePoy & Gitlin 2011: 25). In the context of this study a positivist 
approach will allow for the measurement of acceptability of imaging through self-reported 
scoring, addressing the research aim and the first objective. This approach allows for different 
individuals' experiences to be collectively measured so that an overall objective picture of 
imaging acceptance can be obtained. Although quantitative methodologies are usually 
associated with deductive reasoning and the testing of existing theory (Bryman 2016: 21), 
logical positivism can support an inductive process whereby observations can support and 
develop existing and new theory (Bowling 2014: 214; DePoy & Gitlin 2011: 31-33; Igo 2017: 2). 
The interpretivist ontological perspective states that reality is subjective to individual experience 
and is constructed through an individuals’ interactions with the world around them (DePoy & 
Gitlin 2011: 26). Attempting to group a range of individual experiences through a purely 
quantitative methodology would prevent valuable analysis of individual perspectives that could 
generate theory through induction, vital in addressing the second research objective. Utilising 
interpretivism to support positivism in answering the research question allows for knowledge to 
be created through analysis of individuals interpretations of social, cultural and behavioural 
factors that influence experience (Bryman 2016: 375-377; Igo 2017: 4). 
Having explored how the contrasting paradigms of positivism and interpretivism could be used 
to answer the research question, the paradigm of pragmatism presented itself as a means of 
ensuring a more comprehensive study and a deeper understanding of the phenomena being 
investigated (Doyle, Brady & Byrne 2016: 624, 344). By combining two different methodologies 
it becomes possible to corroborate the findings of each through triangulation, where the same 
data set collected through each methodology supports its counterpart, enhancing validity 
(Bryman 2016: 641; Doyle, Brady and Byrne 2016: 624). A critique of mixed methodologies is 
the possible incompatibility of quantitative and qualitative methodologies due to differences in 
the underlying ontological, epistemological and methodological assumptions (Denscombe 2008: 
273; Doyle, Brady and Byrne 2016: 625; Taylor and Francis 2013: 171). Nonetheless, many 
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authors argue that mixing methods addresses the limitations and offsets the weaknesses of the 
traditional methodologies (DePoy & Gitlin 2011: 99). If only a quantitative or qualitative 
methodology were selected, then an opportunity would be missed to produce a more complete 
picture presented by the data and avoid bias intrinsic to the traditional methodologies 
(Denscombe 2008: 272).  
Pragmatism rejects the traditional dualisms; instead, it accepts the importance of both the 
physical world and the social and psychological world (Johnson and Onwuegbuzie 2004: 18). 
Whilst pragmatism is recommended for use in nursing and healthcare research (Doyle, Brady 
and Byrne 2016: 632), all data produced through such an approach must be considered, not just 
the data that is convenient to the agenda of the researcher (Johnson and Onwuegbuzie 2004: 
23-24; Denscombe 2008: 279).  
3.2 Design 
To answer the research question and aims, a mixed method, non-experimental, retrospective, 
cross-sectional survey study was used.   
An embedded mixed methods design was applied, whereby the qualitative component of the 
research is embedded within the quantitative component (Bryman 2016: 639; Bowling 2014: 
421; Doyle, Brady and Byrne 2016: 628-629). This design was selected as it is appropriate for 
research that attempts to collect data for both components simultaneously, and when either the 
quantitative or qualitative component will form a greater part of the study. For this study, 
quantitative data forms the larger component. The qualitative data will allow for ‘explanation’ of 
the quantitative results, with the qualitative component providing a deeper insight into the 
findings of this research (Bowling 2014: 419; Bryman 2016: 64). 
This study used a non-experimental survey design to answer the research question, as no 
intervention was tested and no variables manipulated. Survey designs are effective in health 
research for describing population parameters and predicting relationships between different 
characteristics across a sample (Bowling 2014: 215; DePoy & Gitlin 2011: 114-115). In the 
context of this study, these characteristics include the physical parameters of the imaging 
experience, and individuals’ intrinsic factors such as pain and anxiety. The research explored in 
chapter 2.5 has influenced the design of this study and by adopting a similar approach, 
comparison with this work is possible (Adams et al. 2014; Evans et al. 2018; Oliveri et al. 2018). 
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A cross-sectional design enabled the collection of data over a relatively short period of time, and 
without follow-up (Hulley et al. 2013: 85). This allowed for a realistic approach to data collection 
within the time available to conduct this project and given the relative scarcity of the myeloma 
population.  
It was necessary to use a retrospective design in order to sufficiently increase the sampling 
frame, as myeloma is not a common condition. Stull et al. (2009: 933) conducted a systematic 
review of recall bias in health research and found that there is frequently an inverse relationship 
between the length of the recall period and accuracy. However, this recall bias is partly offset by 
the phenomena participants are being asked to recall and its possible impact. For example, 
having a whole-body scan is a specific infrequent event as opposed to ongoing frequent events 
such as a weekly blood test. Stull et al. (2009: 931-932) stated that specific events with greater 
significance are likely to be recalled more accurately even with a longer recall period. Although 
a prospective design would have the benefit of eliminating much of the recall bias, it would 
significantly impact the sampling frame which would have a greater impact on validity (Bowling 
2014: 320).  
3.2.1 Survey Instrument Design 
Questionnaires are frequently used in health and social care research to collect data (Bowling 
2014: 275-276) and have been successfully used in the research critiqued in chapter 2.5. They 
are appropriate for descriptive studies and descriptive research questions, where variations in 
the characteristics of different groups or elements are to be compared (Saks & Allsop 2012: 
192). Surveys can also be used to uncover cause and consequence between the elements 
being studied although defining the causality between variables is not possible (Bowling 2014: 
216; Saks & Allsop 2012: 192). Hulley et al. (2013: 223) asserts the importance of the quality of 
the survey instrument, in this case, a questionnaire, as the validity of any inferred results will be 
dependent upon it. 
It was outside the scope of this study to design and validate a new questionnaire, although a 
bespoke questionnaire has been implemented that was based upon two previous 
questionnaires evaluating the acceptance of radiology examinations (Salmon et al. 1994; 




A literature search of published research relating to surveys of patient perceptions and 
acceptance of radiology imaging was carried out to identify whether a validated survey exists 
that allows respondents to compare several imaging modalities or to uncover a survey 
instrument that is used as an industry standard. CINAHL and MEDLINE databases were 
searched with papers from the previous 10 years included in an effort to reflect current practice. 
The search terms were the same as those used for the literature review in table 2.1. The most 
refined search yielded 139 results. Titles and abstracts were reviewed, and relevant papers 
identified. The reference lists of relevant papers were used to identify other research relevant to 
surveying experiences of radiology, some of which were published prior to 2009 but included 
due to their impact. It is worth noting that the research mostly focused on cardiac, lower gastric 
or general oncology imaging. No research papers were identified that included surveys relating 
to whole-body imaging specifically for myeloma. 
Each survey instrument used in the thirteen selected papers were reviewed and their use 
considered against the following criteria; whether the survey instrument had been validated, 
what sort of scale or open text responses were used, the number of questions and the sample 
size that the survey instrument has been used upon. The results of this review are summarised 




Table 3.1: Summary of the survey instruments used measuring acceptance of imaging 
 Scale used (most 
frequently) 
Open questions 
or space for 
additional 
comments? 





Adams et al. 
2014 
Rating scale 1-4.  No 6 per modality 
Total 12 
36 
Evans et al. 
2018 
Rating scale 1-7  No (separate 
qualitative work 
undertaken) 
28 per modality  
Total 46 
115 
Feger et al. 
2015 
Rating scale 1-5 
VAS for pain 
Yes, plus a table 
for pros and cons 
Total 31 48 
Gleuker et al. 
2003 
Rating scale 1-5 (1 
question 1-3) 
No Total 11  1053  
Heyer et al 2015 Likert 1-4 (descriptors 
the same across all 
questions) 
No STAI-S (20 questions) 
Supplementary questions 
(10 questions). Total 30 
825 
Oliveri et al. 
2018 
Rating scale 1-5 One question 
regarding prior 
concerns 
Total 24 135 
Prasad et al. 
2019 
Numerical rating scale 
1-5.  
Yes - A single 
section at the end. 
18 per modality 
Total 38 
41 
Rief et al. 2015 Rating scale 1-5  
VAS for pain 
Yes, plus a table 
for pros and cons 
8 per modality 
Total 16 
90 
Salmon et al. 
1994 




et al. 2007 
Rating scale 1-5. Yes, plus a table 
for pros and cons 
7 per modality 
Total 21 
111 
Svensson et al. 
2002 
Rating scale 1-4 Yes, several 
opportunities 




Taylor et al. 
2003 
Rating scale 1-7 No 25 per modality 
Each respondent would 
have 1 or 2 modalities. 
Total 25 or 50 
140 
von Wagner et 
al. 2011 





The research papers that failed to report the basis for a survey instrument used or had utilised a 
bespoke questionnaire without providing a reasonable rationale for its development and use 
were discounted. This left three core papers that either used a validated survey instrument, or 
the instrument had been demonstrated to be effective and used by other researchers. These 
original survey tools are those developed by Salmon et al. (1994), and Schönenberger et al. 
(2007). The standardised state-trait anxiety inventory (STAI-S) utilised by Heyer et al. (2015) 
was also considered at this stage as it is a widely used instrument to measure anxiety and has 
been effectively used to measure patient anxiety during MRI (MacKenzie et al. 1995).  
Considering the research aims was fundamental in deciding which survey instrument should be 
used as the basis for this study. As the purpose of this study is to uncover the ‘acceptability’ of 
different imaging techniques, a measure solely of anxiety, such as the STAI-S, may not fully 
uncover the range of burdens a patient can experience during imaging or aspects of the 
experience that can ease the burden. Due to the limited available sampling frame, maximising 
responses was a key consideration in developing a survey fit for purpose. As the STAI-S 
consists of 10 demographic questions and a further 20 questions that would have to be 
repeated for each modality being investigated in this study, it’s relative complexity may have led 
to high questionnaire fatigue and impacted the response rate (Bryman 2016: 225-226; Hulley et 
al 2013: 231). The STAI-S does not use any open responses, although it may have been 
possible to add these had it been selected for use in this study. 
The survey instrument created by Schönenberger et al. (2007) was chosen as the core survey 
to be used in this study for several reasons. Firstly, it proved effective in their research, 
demonstrating results at a significance level of p = 0.002. Secondly, it consists of seven 
relatively simple questions repeated for each imaging technique being compared. As stated 
previously, a concise questionnaire may improve response rates (Bryman 2016: 225-226) 
although Bowling (2014: 285) contradicts this, citing two separate studies that reported 
response rates being the same among surveys with four pages, twelve pages or sixteen pages.  
Schönenberger et al. (2007) made provision for free text responses, specifically in a table 
inviting the respondent to state what they perceive the advantages and disadvantages of each 
imaging technique to be. Free text responses have provided the qualitative data required for the 
mixed-methods design adopted in this study. Finally, the survey instrument developed by 
Schönenberger et al. (2007) has been effectively used in two other studies evaluating patient 
acceptance of cardiac imaging conducted by Feger et al. (2015: 2117) and Rief et al. (2015: 3). 
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It should be noted that Schönenberger is listed as an author on both of these studies, although 
Oliveri et al. (2018: 247) have also adapted this survey instrument for use in their own study. 
Both Feger et al. (2015: 2117) and Rief et al. (2015: 3) claim that the survey instrument 
developed by Schönenberger et al. (2007) has been validated, although specific validation work 
does not appear to have been published. They may be referring to the effective use of this 
survey in the original research conducted by Schönenberger et al. (2007).  
The validated survey instrument developed by Salmon et al. (1994) was originally for the 
purpose of evaluating patient acceptance of colonoscopy. This survey instrument has been 
adapted by several other researchers for use in their own studies (Taylor et al. 2003; von 
Wagner et al. 2011) to allow for a comparison of colonoscopy with computerised tomography 
colonography, a newer technique used for imaging the large bowel. It has also been used by 
Evans et al. (2018) to compare WB-MRI with other imaging techniques. Despite the relative 
complexity of this survey instrument in terms of the length and depth of the questions, the 
rigorous process of its development and its potential to enhance the validity of inferred results 
cannot be overlooked.  
Saks & Allsop (2012: 193) explained that a survey instrument contains constructs; summaries of 
the characteristics being investigated that are translated into indicators, or questions. Identifying 
constructs is the first phase of developing a survey (Fayers & Machin 2016: 61-62). Key 
constructs that overlap in both surveys by Salmon et al. (1994) and Schönenberger et al. (2007) 
are comfort, pain, feeling helpless or in control, and overall satisfaction. A construct additionally 
addressed by Schönenberger et al. (2007) relates to concern and preparation prior to the 
imaging examination. The survey instrument developed by Salmon et al. (1994) and adapted by 
von Wagner et al. (2011) addresses the constructs of staff support, patients’ understanding of 
the imaging examination, claustrophobia, stress and anxiety. In developing the survey 
instrument used in this study, questions that address each of the constructs listed above were 
included. Two additional constructs were also identified in research investigating the acceptance 
of WB-MRI (Evans et al. 2017: 1, 4; Oliveri et al. 2018: 250).  The first construct investigates the 
time spent in the scanner, or the time taken for the examination. The second construct 
investigates the use of ionising radiation.  As the different whole-body imaging methods used for 
diagnosing myeloma are associated with different examination times and different doses of 
ionising radiation it was appropriate to include these constructs. The survey instrument adapted 
for this study contained questions for each of these constructs, summarised in table 3.2, in 
addition to the type of data gathered and the shortened term used for each construct. 
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Table 3.2: Summary of the 11 constructs affecting acceptance 
Evans et al. (2017); Oliveri et al. (2018); Salmon et al. (1994); Schönenberger et al. (2007) 
Construct Short Title Type of Data 
Worry prior to whole-body imaging  Prior Worry Ordinal 
Patient understanding of their whole-body 
imaging 
Understanding Ordinal 
Pain during whole-body imaging Pain Ordinal 
Stress or anxiety during whole-body 
imaging 
Stress During Ordinal 
Claustrophobia experienced during the 
whole-body imaging 
Claustrophobia Ordinal 
Patient feeling in control during their whole-
body imaging 
Control Ordinal 
Staff support during whole-body imaging Support Ordinal 
The comfort of whole-body imaging Comfort Ordinal 
Overall experience of whole-body imaging Overall Experience Ordinal 
Difficulties with the length of whole-body 
imaging 
Length Nominal 
Concerns over the use of x-rays or 
magnetic fields 





3.2.2 Survey Review Process 
The second phase of designing a survey instrument was to translate the constructs and issues 
into questions and decide the response format (Fayers & Machin 2016: 68-70). An initial set of 
questions was drafted using the survey instrument developed by Schönenberger et al. (2007) as 
a template, with questions for the remaining constructs included. The responses to the closed 
questions mostly used categorical rating scales where the respondent is presented with five 
choices ranging from the greatest negative response to the greatest positive response. Labels 
such as ‘not at all’ to ‘completely’ were used instead of numerical rating scales (NRS) to 
normalise individual responses and prevent respondents from applying a subjective value to an 
arbitrary 1-5 scale. The wording of the labels was amended to improve clarity, simplicity and 
neutrality of the adapted survey to enhance the reproducibility and validity of the responses 
(Bowling 2014: 312-314; Hulley et al. 2007: 227). Open-ended questions were included to 
provide the respondent with the opportunity to elaborate on answers given in the closed 
questions in addition to the comparison table of each imaging modality designed by 
Schönenberger et al. (2007). Two questions required only nominal responses. In both instances 
these were a binary yes or no choice. 
The adapted survey instrument went through a review process, summarised in appendix 3, 
which generated much discussion regarding the syntax and semantics of the questions. The 
first review was by both academic and clinical colleagues active in research, some of whom 
have experience in radiology and myeloma. This was an important step in confirming the survey 
instrument’s content validity and assuring the questions would be able to measure the 
constructs identified for investigation (Fayers & Machin 2016: 90-93). The subsequent draft was 
piloted with five clinical staff members from three different professions who are involved in 
research. Additionally, the questionnaire was reviewed by the author’s academic supervisory 
team on three separate occasions. The purpose of this review was to confirm the adapted 
surveys face validity. 
To confirm the construct validity of the survey, in that it will effectively measure the constructs 
that it has been designed to measure (Fayers & Machin 2016: 96-98), convergent validity and 
discriminant validity of responses has been tested using Spearman’s correlation coefficient 
(Field 2018: 351-352). This method ensures consistency across groups within the entire dataset 
by testing the consistency of responses for a construct against each other construct. Construct 
validity is reported on in chapter 4.2.6.  
50 
 
Upon completion of survey version 6, the questionnaire was redrafted using Online Survey (Jisc 
2019) software providing an attractive and clear layout in order to increase the response rate 
(Bryman 2016: 225-226) and to make provision for printing paper copies and completion online. 
During the development of the survey instrument, the participant information sheet and consent 
statement were drafted using a template provided by Coventry University. The survey 
instrument developed by Schönenberger et al. (2007) used a visual analogue scale (VAS) to 
enable the respondent to report their level of pain. As the Online Survey (Jisc 2019) has no 
provision for a VAS, a ten-point NRS was used. A systematic review of the clinical measures for 
pain by Harrington et al. (2018: 84) highly recommends the use of NRS for measuring pain, 
scoring its effectiveness as being equal to the VAS.  
The third phase of survey design is to pre-test the survey instrument (Fayers & Machin 2016: 
74-75). The first pass of this was with clinical and academic colleagues, seven in total. This was 
to identify issues of ambiguity, wording, semantics and clarity. After revising the survey, it was 
then given to a local NHS Patient and Public Involvement in Research (PPI) group for further 
review and criticism, before final revisions were made addressing further feedback from 
healthcare practitioners. This process has been important in further ensuring the face and 
content validity of the proposed survey. The amendments made throughout the development of 
the survey have been summarised in appendix 3, and the final survey is available in appendix 5. 
3.2.3 Patient and Public Involvement Group Review 
The organisation INVOLVE, on behalf of the Health Research Authority (HRA), have published 
guidance on the use of patient and public involvement in research (PPI) groups. They state that 
potential benefits can include the researcher being provided with a different perspective and 
improving the quality of the research. This could be through reviewing the language and content 
of participant facing material, ensuring that the outcomes are of value and increasing public 
participation in research projects (2012: 8). UHCW’s PPI group was accessed to review the 
bespoke questionnaire that was to be implemented. Five members of the public agreed to 
review the questionnaire, providing a second opportunity to pre-test the survey (Fayers & 
Machin 2016: 74-75). Obtaining a non-expert opinion demonstrated parts of the survey that 
were clear and well understood, as well as highlighting ambiguous wording. One of the PPI 
reviewers also identified a key question that could be added in order to obtain further qualitative 
data; where the respondent is asked whether they understood the examination that they are 
having it was suggested to include the question, ‘If not, what could be clarified?’. The process of 
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PPI review proved to be of great benefit as several potential issues were identified that had not 
been apparent to the clinical or academic reviewers. As a result, these issues were addressed, 
and amendments made to further improve the face validity of the survey instrument (Fayers & 
Machin 2016: 90-93). A summary of the amendments and the full feedback letter from the 
UHCW PPI group are available in appendices 3 and 4. 
3.2.4 Helplessness and Control 
The survey developed by Schönenberger et al. (2007) incorporated a question asking 
respondents to rate their feelings of helplessness. In adapting their survey instrument for use in 
this study, this question was met with criticism by members of the clinical peer group and the 
supervisory team. Additionally, the wording of the follow-up open-ended question requesting 
further details about helplessness was queried by one of the PPI reviewers. The first issue 
raised was whether this was a leading question; by asking a respondent to report their feelings 
of helplessness it is possible that they will indicate some helplessness even if they had not 
considered it prior to being asked. The semantic meaning behind the question was examined in 
depth. Mosby’s Dictionary of Medicine, Nursing and Health Professions (2017) defines 
helplessness as being, ‘a feeling of a loss of control or ability, usually after repeated failures, or 
of being immobilised or frozen by circumstances beyond one’s control, with the result that one is 
unable to make autonomous choices.’ Whether the question could be a useful indicator of a 
negative emotional state was contemplated. In an effort to obtain further information about the 
development and inclusion of the question, attempts were made to contact the corresponding 
author stated in the research conducted by Schönenberger et al. (2007) but no response was 
received. It was decided that this question could be replaced with an equivalent question from 
the work conducted by Salmon et al. (1994) regarding the construct ‘control’. The concept of 
control is a key component relating to patient influence over a situation and a positive emotional 
state, although Salmon et al. (1994: 344) argue that it can also be modestly associated with 
physical discomfort. Understanding whether a patient feels in control during whole-body imaging 
is useful in further understanding the perception of the imaging techniques, especially when 







3.3.1 Ethics  
This study was subject to the research governance legislation of the United Kingdom’s HRA 
which is outlined in the UK Policy Framework for Health and Social Care Research (2017). As 
well as reviewing this policy, advice was sought from the UHCW’s Research and Development 
department as this study involved the survey of NHS patients. The Society and College of 
Radiographers (2013) code of conduct and the British Psychological Society Ethics Committee's 
Guidance on the use of social media (2012) were both reviewed to ensure this project complies 
with this guidance, as per Coventry University's policy on research ethics. 
In conducting a survey on patients with a treatable but incurable condition sensitivity towards 
discussing myeloma must be at the forefront of the study design. Any potential participant that 
was approached to take part may have no wish to contemplate any aspect of their condition and 
care, nor provide details unnecessarily (HRA 2017: 12-13).  
The risks and burdens in this study came from asking participants to consider their condition 
and give details about the imaging experiences they have had. It is possible that some 
participants had negative experiences that they revisited in order to complete the survey or 
could have found it emotionally distressing to consider aspects of their condition. Participants 
were informed in the participant information sheet that they will be asked questions relating to 
their experience and their condition. This allows the participant the opportunity to consider 
whether they wish to take part. In order to ensure non-maleficence, participants were informed 
of the content of the survey and how they can withdraw at any time (Bowling 2014: 183). Details 
on how to obtain further support through the participants healthcare provider or a myeloma 
charity were provided at the end of the survey to address any concerns raised and to ensure 
that the ethical principle of beneficence is adhered to. 
A second potential burden came from participants having concerns about being asked about a 
whole-body imaging technique that they have not had or were not offered. This could lead to 
feelings that individuals were not consulted when being referred for imaging, even when the 
referring clinician chose the most appropriate imaging technique for that particular patient. To 
address this the questionnaire aimed only to obtain a ‘snapshot’ of experience. A statement on 
the questionnaire informed participants that all of the whole-body imaging methods mentioned in 
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the questionnaire are valid and widely used within the NHS (see appendix 5). It is important not 
to undermine the expertise of the referring clinician and the patients’ trust in their healthcare. 
To ensure compliance with research governance and the General Data Protection Regulations 
(GDPR 2018), no databases were used to identify potential participants. No identifiable or 
personal data was obtained as it is not required for this study. This is in line with the GDPR 
principles of data minimisation and integrity and confidentiality. 
Applications to the Coventry University ethics committee and the HRA were submitted for this 
project (page i and appendix 1). Following ethical approval, applications for participation at three 
NHS trusts were submitted. The charity, Myeloma UK, were also contacted to allow access to 
their service users. All the project documents were sent to the Coventry University ethics 
committee, HRA and each site for review. Throughout the duration of the study two non-
substantial amendments were submitted to change document wording, and to allow for the 
inclusion of the MGUS group, as advised by the HRA Research Ethics Committee (REC). 
Further detail is provided in chapter 3.3.4. 
3.3.2 Consent 
The UK Policy Framework for Health and Social Care Research (HRA 2017; 6) states that 
informed consent must be given prior to any research activity. This would include using 
databases or other records that fall under GDPR to identify and approach participants if it is 
outside normal clinical care provided by the researcher. To address this, clinical teams were 
given information about the study to pass on to patients. Additionally, participants for this study 
were approached passively through an advertising flyer (paper or online) allowing them to 
decide whether they wish to obtain further details about the study. 
In an effort to simplify the process of consent for this study and to comply with GDPR it was 
decided not to obtain any identifiable information, including when recording consent. The 
consent section of the Integrated Research Application System (IRAS) confirmed recorded 
consent is not always necessary for survey studies, as the return of the questionnaire is 
evidence of implicit consent. Guidance produced by the HRA (2018a: 16; 2018b: 5-9) regarding 
proportionate approaches to receiving consent, by post and electronically, states including a tick 
box or simple electronic signature is appropriate for low-risk research at this level. As per this 
guidance, a participant statement was prepared to ensure potential participants have sufficient 
information to reach an informed decision regarding their participation. At the end of this 
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statement is a short declaration that the participant must tick stating that they understand the 
information provided to them and consent to take part (available in appendix 5). This allowed for 
consent to be obtained and recorded whilst still protecting the confidentiality of all respondents. 
3.3.3 Sampling and Recruitment 
A purposive self-selection sampling method was used to ensure respondents have the relevant 
knowledge to provide data that will answer the research question (Bryman 2016: 408; 
Denscombe 2017: 41) whilst also ensuring a sufficient sampling frame as myeloma is an 
uncommon condition (Bowling 2014: 199).  A problem with purposive sampling is the 
introduction of sampling error, whereby the sample is not truly representative of the entire 
population and so introduces bias into the results due to skewed responses (Bowling 2014: 200-
201). This bias could be reduced if a probability sampling method was employed (Bryman 2016: 
174; Saks & Allsop 2012: 174-175) but due to the requirement for participants to be able to self-
select for this study, it was not practical to adopt this approach. Instead, the sampling frame was 
maximised to invite the largest number of potential respondents as possible and reduce the 
introduction of bias due to sampling error. In order to increase the sampling frame within the 
limits of the resources available, participants were recruited from one of three NHS Trusts: 
UHCW NHS Trust, George Eliot Hospital NHS Trust (GEH) and South Warwick Foundation 
Trust (SWFT). In addition, the Myeloma UK charity was also approached to advertise the study 
to their service users, alongside other advertisements to UK based online myeloma support 
groups and social media. This increased the sampling frame from the local geographic area to 
the whole of the UK which will enhance the external validity of results (Gray, Grove & 
Sutherland 2017: 222). Finally, by using a retrospective design, the sampling frame was further 
increased (Bowling 2014: 320). 
Non-response in a survey study is another means by which bias can be introduced (Bowling 
2014: 180; Bryman 2016: 184-186). For this study, the concern was that only those who have 
had specific experiences will complete the survey. For example, if a participant had a 
particularly good or bad experience of whole-body imaging it is quite possible that they would be 
more inclined to complete the survey, and the non-responders would be those who had no 
specific experiences of acceptability of myeloma imaging. Although it is impossible to 
specifically identify where such bias exists it must be recognised and considered when 
analysing the results. In an effort to address this bias, steps were taken to improve response 
rates whilst still allowing respondents to participate willingly and without coercion. These 
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included a clear participation information statement and making the survey layout clear and 
easy to read. Stamped addressed envelopes were provided for postal surveys (Bryman 2016: 
225). These were given to clinical teams to handout to potential respondents. Providing an 
incentive for completion was outside the scope and resources of this study.  
3.3.4 Inclusion and Exclusion Criteria 
To answer the research question, the sample must include respondents who have experienced 
whole-body imaging for the diagnosis of myeloma lesions. It was initially decided to exclude the 
MGUS group as having imaging that excludes disease may naturally be viewed positively and 
introduce a bias that would render meaningful results indeterminable. The HRA Ethics 
committee asked for justification for this exclusion as the experience of having whole-body 
imaging is the phenomena being investigated. Following discussion with the research team and 
a Consultant Haematologist, it was decided to include all those who have received imaging for 
myeloma or any of its precursor conditions including MGUS. This would increase the sampling 
frame and allow a broader range of experiences of imaging to be recorded. 
In an attempt to control for recall bias, excluding participants whose most recent experience of 
whole-body imaging was greater that 6 months ago was initially one of the exclusion criteria. 
This six-month period was an arbitrary value; as discussed in chapter 3.2, there is no standard 
recall period for measuring or understanding phenomena (Stull et al. 2009: 940). As a number 
of respondents who had experienced imaging more than six months ago still completed the 
survey and provided valuable data it was decided to include all responses. 
To meet the governance requirements outlined in the ethics application, respondents were 
required to be 18 years or over and have the capacity to read and understand the patient 
information statement and indicate their consent. This may impact the involvement of 
respondents who are unable to read English, although no requests were made requesting a 





Table 3.3: Inclusion and exclusion criteria for participation in the study 
Inclusion Criteria Exclusion Criteria 
Has experienced whole-body imaging to 
investigate myeloma, asymptomatic myeloma 
or MGUS in the UK 
Has not had specific whole-body imaging. 
Aged 18 years or over. Under the age of 18. 
The capacity to consent, understand and 
complete the survey study. 
Does not have the capacity to consent, 
understand and complete the survey study. 
 
3.3.5 Sample Size and Participants 
A sample size was estimated assuming analysis with the one-way analysis of variance 
(ANOVA) parametric statistical model (Cohen: 1992). One-way ANOVA was used to guide the 
sample size estimate as McDonald (2014: 164) and Fan, Zhang and Zhang (2011) all highlight 
the difficulties in estimating a required sample size for non-parametric statistical models. 
The conventional values of 0.05 for α error probability (p = 0.05), a statistical power of 0.8 (1-β 
error probability, 1-0.2) and a medium effect size of f = 0.25 were selected to calculate the 
estimated required sample. These are conventions proposed for general use in health and 
social care research (Taylor and Spurlock 2018). 52 responses would be required for each 
imaging modality, leading to a sample of 156 sets of responses. This sample estimate was also 
confirmed using G*Power software (Faul et al. 2009). The quantitative component of this study 
dictated the sample size for the qualitative component.  
3.3.6 Data Collection  
Data was collected over a period of four months from November 2019 to March 2020. The 
decision was taken to cease data collection at the time of the Covid-19 pandemic due to the 
significant effect the pandemic had on public access to healthcare services. Combined with a 
media campaign supporting healthcare workers, variables could be introduced that cannot be 
controlled for. Across the United Kingdom (UK) many non-urgent imaging appointments were 
being postponed or cancelled by both patients and healthcare providers. Myeloma patients also 
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fall into one of the high-risk groups for Covid-19 and should avoid the risk of exposure where 
possible.  
62 individuals completed the survey, two of which were excluded. One was based outside of the 
UK, and another had not experienced any of the imaging techniques being investigated. The 60 
included respondents provided a total of 121 sets of responses across the three imaging 
modalities. As this is 35 responses short of the initial sample size estimate of 156 data sets an 
effect size calculation for the achieved sample size was performed and reported upon in chapter 
3.3.7.  
3.3.7 Quantitative Analysis Methods 
Participant demographics were analysed to illustrate ‘who’ the participants were and 
contextualise results. SPSS V25 (IBM 2020) was used to perform descriptive and statistical 
analysis, and for producing charts and tables. The responses given on the categorical rating 
scales for each construct within the survey were converted to numerical acceptance scores for 
analysis. 
Test of Normality 
As the research data obtained is from a survey it was expected that this data would not follow a 
normal distribution and would require non-parametric statistical tests to be used for analysis. To 
confirm this, the Kolmogorov-Smirnov test was applied to each construct in the dataset (see 
table 3.2 for a list of constructs) (Field 2018: 249-251). This test will compare the scores in the 
dataset to a normally distributed set of scores with the same mean and standard deviation as 
the dataset. The Kolmogorov-Smirnov test demonstrated that the data for each survey construct 
deviated significantly from the norm (p = <0.001). The Kolmogorov-Smirnov statistic for each 
survey construct measured with ordinal data were as follows; worry prior to imaging, D (df 120) 
= 0.281; understanding the procedure D (df 120) = 0.278; stress D (df 121) = 0.276; 
claustrophobia D (df 121) = 0.275; feeling in control D (df 119) = 0.255; feeling supported by 
staff D (df 120) = 0.372; comfort D (df 120) = 0.210; overall experience D (df 121) = 0.239. This 
demonstrates that the data does not follow a normal distribution and should be analysed with 
non-parametric statistical models. A second test of normality that can be applied to the pain 
scores reported by respondents is through calculation of the kurtosis and skew using SPSS V25 
(IBM 2020). These values indicate whether the data is either above, below or either side of the 




Statistical Tests and Effect Size 
As the estimated required sample was not met, calculating the effect size of the achieved 
sample will demonstrate the magnitude of differences between groups in any observations 
made using the survey instrument (Field 2018: 113). Using G*Power software (Faul et al. 2009), 
an effect size of f = 0.286 was calculated using the achieved sample size of 121 responses, the 
same α and β error probabilities as the sample estimate calculation in chapter 3.3.5 and the 
one-way ANOVA statistical model. This effect size lies between the medium (0.25) and large 
(0.4) effect sizes described by Cohen (1992: 156). This demonstrates that as the sample size of 
156 was not achieved the statistical analysis may not be sensitive in observing smaller effects 
(<0.286) within the data as measured by the size of the standard deviations from the mean 
(Field 2018: 114-120). These calculations assume a normal distribution of data, although as 
demonstrated above, the data obtained does not meet this assumption and an effect size 
appropriate for a non-parametric statistical model must be calculated. 
To compare all three whole-body imaging modalities, the Kruskal-Wallis test was used as the 
data is not normally distributed (McDonald 2014: 157-164; Field 2018: 286-316). Where 
statistically significant results were demonstrated, additional pairwise analysis was performed to 
demonstrate the differences between two different groups or pairs of imaging modalities. Part of 
this pairwise analysis requires the calculation of post-test effect sizes, r, using the following 






The calculated effect sizes have been reported on in chapter 4.2.2 and again serve to 
demonstrate the magnitude of differences observed using the survey instrument. The non-
parametric effect size, r, can be approximately compared to the parametric effect size calculated 
using Cohen’s f given above. A limitation here is f assumes more than two groups and a 
parametric model whereas the post-test effect size, r, is calculated against pairs using a non-
parametric model. Using an effect size calculator, Pyschometrica (Lenhard & Lenhard 2016), it 
is possible to convert Cohen’s f to r, and vice versa. Cohen’s f = 0.286 equates to r = 0.275, 
whilst f = 0.577 equates to r = 0.5. This indicates that for smaller effects sizes of < 0.3, r and f 
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may be comparable, although at effect sizes of > 0.5 the differences may be more pronounced 
with the value of f being greater than r. 
The Mann-Whitney U test was used when two independent groups were being compared. The 
Wilcoxon signed-rank test was used for analysing dependent pairs of variables. Spearman’s 
correlation was used to analyse multiple variables measured with ordinal or ranked data.  
Across all statistical testing, where outliers are identified that have the potential to bias results, 
they have been marked on boxplots to indicate to the reader where the outliers were in the data 
(Field 2018: 227-229). Outliers are scores that are 1.5 times greater than the IQR. 
As multiple statistical tests were performed on the data, the possibility of a type I error increases 
(Field 2018: 308). Therefore, the p-values in the analysis were adjusted using the Bonferroni 
correction when appropriate, reducing the probability of making a type I error (Field 2018: 83). 
The convention for this is to divide the conventional significance level, p = 0.05, by the number 
of statistical tests to give the adjusted p value. McDonald (2014: 254-26) warns a very low p 
value calculated this way can reduce the statistical power and increase the chance of type II 
errors. 
3.3.8 Qualitative Analysis Method 
A qualitative description approach has been described by Bradshaw, Atkinson and Doody 
(2017: 1) as an appropriate method for healthcare researchers who have limited experience of 
complex qualitative methodologies. Qualitative description allows the researcher to understand 
the phenomenon being investigated and the perspective of those involved. It is an inductive 
process whereby it can add to existing knowledge and recognises the subjectivity of individual 
responses and the influence of the researcher (Bradshaw, Atkinson and Doody 2017: 2). 
Bradshaw, Atkinson and Doody (2017: 1, 5) state it as being suitable for mixed methods 
research and recommend thematic analysis as the named framework for data analysis. 
Thematic analysis is a widely used and flexible qualitative analytical method described by Braun 
and Clark (2006: 78) as being a foundational method suitable for the novice qualitative 
researcher. Whilst thematic analysis can be suitable for a number of qualitative methods from 
different epistemological positions and methodologies, within this study it has been used from 
the perspective of qualitative description (Braun & Clark 2006: 78; Saks & Allsop 2012: 139-
140). This enables the examination of personal lived experience without requiring the theoretical 
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and technical knowledge of interpretative phenomenological analysis methodology (Smith & 
Osborne 2015: 41-42). The data was reviewed at a ‘semantic’ level where analysis focused on 
describing what participants have written and patterns within the content (Braun & Clark 2006: 
84). This is followed by interpretation of the semantic level analysis so that conclusions can be 
made regarding its significance and implications. The limitation of thematic analysis at a 
semantic level is that it is not possible to attempt to investigate the underlying concepts and 
assumptions at a deeper level using latent level analysis (Braun & Clark 2006: 84). Given the 
relatively ‘light’ level of qualitative data collected in this survey, it would not be appropriate to 
attempt a deep latent level analysis, an approach more appropriate for detailed data, such as 
focus groups and interviews. As stated in chapter 3.1, by considering an interpretivist 
ontological perspective whereby reality is subjective to individual experience, then using 
thematic analysis from a realist epistemology allows for a straightforward analysis of individual 
responses (DePoy & Gitlin 2011: 26). A unidirectional relationship between a respondent’s 
meaning and their experience is assumed (Braun & Clark 2006: 85), meaning that what a 
respondent has written directly expresses their experience. Although this is a relatively simplistic 
qualitative standpoint, it is again appropriate to the level of qualitative data obtained within this 
project and correlates to analysis at a semantic level.  
Process of Thematic Analysis 
To demonstrate the dependability and trustworthiness of the data analysis, a fully reported audit 
trail of the thematic analysis process is provided here, with additional details in appendices 6, 7, 
and 8 (Murphy and Yielder 2010: 65). Thematic analysis is a both a reflexive and iterative 
process. The effect of the researcher’s involvement in the interpretation of respondents meaning 
has to be taken into account, while results and analysis develop together as repeated analysis 
continues to shape and refine the data (Murphy and Yielder 2010: 65-66). QSR International’s 
(2020) NVivo V12 software was used to manage and analyse the open text data. The 6 phases 




Table 3.4: Summary of the six phases of thematic analysis  
Reproduced from Braun and Clark (2006: 87) 
Phase Description 
1. Familiarizing yourself with 
your data 
Transcribing data (if necessary), reading and re-reading the 
data, noting down initial ideas. 
2. Generating initial codes Coding interesting features of the data in a systematic 
fashion across the entire data set, collating data relevant to 
each code. 
3. Searching for themes Collating codes into potential themes, gathering all data 
relevant to each potential theme. 
4. Reviewing themes Checking if the themes work in relation to the coded extracts 
(Level 1) and the entire data set (Level 2), generating a 
thematic ‘map’ of the analysis. 
5. Defining and naming 
themes 
Ongoing analysis to refine the specifics of each theme, and 
the overall story the analysis tells, generating clear 
definitions and names for each theme 
6. Producing the report The final opportunity for analysis. Selection of vivid, 
compelling extract examples, final analysis of selected 
extracts, relating back of the analysis to the research 
question and literature, producing a scholarly report of the 
analysis. 
Phase 1: Familiarity 
The author reviewed each respondent’s survey to confirm its internal consistency. To ensure the 
trustworthiness of completed surveys, individual responses were assessed for consistency to 
ensure that there is no discrepancy between negative and positive responses. Reading through 
each respondents’ survey ensured the author was familiar with the qualitative data. 
Phase 2: Initial Codes 
The author reviewed each written response and assigned one or more codes to them using 
NVivo V12 (QSR International 2020). Whilst the author had a strong sense of the initial codes 
that would be used to reflect the constructs being investigated within the survey, additional 
codes evolved. 104 codes were used in total. Some small amount of overlap was noted 
between codes, for example ‘disadvantages of WB-MRI’ partly overlaps with the codes 
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‘claustrophobia’ and ‘stress or anxiety’. Coding in this way allowed for easier reference to 
positive and negative recorded experiences. Each code and the number of times a code was 
assigned to a part of the dataset are listed in appendix 6. Using NVivo V12 (QSR International 
2020) a word frequency table was generated which was used to support the development of the 
codes and themes in subsequent phases. This list is available in appendix 7. 
Phase 3: Initial Thematic Map of Potential Themes 
The data compiled in phase 2 was used to produce a thematic map containing numerous 
themes, presented in appendix 8. Each theme is considered in relation to the research question, 
and whether it captures useful or informative qualitative data (Braun & Clark 2006: 82). Whilst 
prevalence is not necessarily a driving factor in the value of a theme, prevalence certainly 
highlights shared experiences and indicates issues that are of importance to the respondents 
through repeated patterns of meaning (Braun & Clark 2006: 86). At the end of phase three, 80 
themes had been identified for further refinement. 
Phase 4: Refined Thematic Map of Supported Themes 
These candidate themes were reviewed to ensure there was sufficient data to support them. 
Where themes overlapped, they were combined into a single theme encapsulating a broader 
concept. For example, several themes referring to bone damage identified in phase 3 were 
encapsulated into two new candidate themes; ‘imaging identifying bone damage’, and ‘bone 
damage causing pain during imaging’. Braun and Clarke (2006: 93) state that at the end of 
phase 4, the data within a theme should consistently relate to that theme, with each theme 
being distinct. The outcome of phase 4 is a refined thematic map (see appendix 8).  
Phase 5: Final Thematic Map 
The dataset was then reviewed again to check the proposed themes against the data and to 
recode any missed data points as part of the iterative process of thematic analysis (Braun & 
Clarke 2006: 93). Once this process was complete a final thematic map was produced for the 
fifth phase of thematic analysis. Three primary themes and eleven sub-themes were identified. 
The themes were compared against one another to ensure minimal overlap and compared to 
the dataset to ensure each theme captures the importance of the patient experiences. The final 
thematic map and the final phase of thematic analysis, reporting upon the data, will be explored 




4.1 Demographic Analysis 
4.1.1 Age, Sex and Condition 
The mean age of respondents in this study was 59.1 years (median = 58.5 years, IQR = 13, 
range = 39 – 79). 10 respondents (16.7%) were aged 70 years or more.  
Of the 60 respondents, 27 (45%) were male, 23 (38.3%) were female, while the remaining 10 
(16.7%) did not report their sex. Considering only the respondents that reported their sex, 54% 
were male and 46% were female. These demographics are further detailed in table 4.1 
Table 4.1: Age and sex of respondents 
 
Gender 
Total Male Female Not stated 
Age < 40 Count 0 1 0 1 
% of Total 0.0% 1.7% 0.0% 1.7% 
40-49 Count 4 2 1 7 
% of Total 6.7% 3.3% 1.7% 11.7% 
50-59 Count 12 10 3 25 
% of Total 20.0% 16.7% 5.0% 41.7% 
60-69 Count 6 6 5 17 
% of Total 10.0% 10.0% 8.3% 28.3% 
> 69 Count 5 4 1 10 
% of Total 8.3% 6.7% 1.7% 16.7% 
Total Count 27 23 10 60 
% of Total 45.0% 38.3% 16.7% 100.0% 
 
2 respondents (3.3%) reported a diagnosis of MGUS, 8 respondents (13.3%) reported a 
diagnosis of asymptomatic myeloma and the remaining 50 respondents (83.3%) stated they had 
multiple myeloma. Due to the disparate group sizes, sub-group analysis by condition was not 
attempted.  
23 respondents (38.3%) had been diagnosed with their condition over four years ago, 21 
respondents (35%) had been diagnosed between 1 to 3 years ago and the remaining 16 
64 
 
respondents (26.7%) had received a diagnosis in the past 12 months. These demographics are 
further detailed in table 4.2. 
Table 4.2: Respondents condition and time since initial diagnosis 
 
 Time since initial diagnosis Total 
 
Less than 12 
months 1 to 3 years 




Count 5 3 0 8 
  % of Total 8.3% 5.0% 0.0% 13.3% 
 Multiple 
Myeloma 
Count 11 17 22 50 
  % of Total 18.3% 28.3% 36.7% 83.3% 
 MGUS Count 0 1 1 2 
  % of Total 0.0% 1.7% 1.7% 3.3% 
Total Count 16 21 23 60 
 % of Total 26.7% 35.0% 38.3% 100.0% 
 
4.1.2 Types of Whole-Body Imaging Experienced 
The 60 respondents provided data for 121 different experiences of whole-body imaging. RSS 
was experienced by 49 respondents (81.7%), WB-MRI was experienced by 40 respondents 
(66.7%) and LD-WBCT was experienced by 32 respondents (53.3%). Table 4.3 shows the 
grouped examinations that respondents experienced, although no data was collected regarding 
the period of time between an individuals’ imaging experiences.  
RSS, RSS in combination with WB-MRI or RSS with WB-MRI and LD-WBCT were the most 
frequently experienced imaging examinations, accounting for 75.1% of the imaging modalities 
reported. Whilst WB-MRI was also frequently utilised, it appears to be in conjunction with one of 
the other imaging modalities. Only 3 respondents (5%) stated they had only undergone whole-
body imaging with LD-WBCT and 2 respondents (3.3%) just had WB-MRI. Only 11 respondents 




Table 4.3: Cross-tabulation of different imaging examinations experienced by respondent 
condition 
 






Myeloma MGUS  
RSS Count 2 9 2 13 
 % of Total 3.3% 15.0% 3.3% 21.7% 
LD-WBCT Count 0 3 0 3 
 % of Total 0.0% 5.0% 0.0% 5.0% 
WB-MRI Count 0 2 0 2 
 % of Total 0.0% 3.3% 0.0% 3.3% 
RSS and 
LD-WBCT 
Count 0 4 0 4 
 % of Total 0.0% 6.7% 0.0% 6.7% 
RSS and 
WB-MRI 
Count 4 9 0 13 
 % of Total 6.7% 15.0% 0.0% 21.7% 
LD-WBCT 
and WB-MRI 
Count 1 5 0 6 




Count 1 18 0 19 
 % of Total 1.7% 30.0% 0.0% 31.7% 
Total Count 8 50 2 60 





4.1.3 Time since Imaging Experience 
16 of the 60 respondents (26.7%) stated that their most recent experience of imaging was over 
6 months ago. The remaining 44 respondents (73.3%) had all experienced at least one whole-
body imaging modality within 6 months of their completing the survey. Table 4.4 shows the time 
between each imaging experience being performed and reported. 59 (49.2%) of the imaging 
experiences occurred within six months or less of being reported. 


















RSS Count 10 3 11 24 48 
% of 
Total 
8.3% 2.5% 9.2% 20.0% 40.0% 
LD-
WBCT 
Count 4 4 7 17 32 
% of 
Total 
3.3% 3.3% 5.8% 14.2% 26.7% 
WB-
MRI 
Count 3 6 11 20 40 
% of 
Total 
2.5% 5.0% 9.2% 16.7% 33.3% 
Total Count 17 13 29 61 120* 
% of 
Total 
14.2% 10.8% 24.2% 50.8% 100.0% 
  *Data missing for one respondent 
 
While recall bias is difficult to control for, the following analysis has been performed to 
demonstrate that the periods of time since a respondent experienced imaging and then reported 
upon it, is uniform across all three whole-body imaging modalities being investigated. The 
homogeneity of variance for the length of time since each imaging modality was experienced 
was tested. Levene’s test was performed and demonstrated no significant difference, F (df1 2, 
df2 117) = 0.544, p = 0.582 (Field 2018: 257-262). Therefore, any present recall bias should be 





Each respondent was asked to rate the baseline pain that they experience as a result of their 
condition on a NRS ranging from 0-10. Table 4.5 shows the frequency that each level of pain 
was recorded. Whilst the majority of respondents experience a relatively low level of pain, some 
pain was experienced by all except for 8 respondents. 20 respondents (33.34%) reported pain 
scores of 6 or more, indicating a level of pain that can have an adverse effect on the quality of 
life (Harrington et al. 2018: 87). The mean pain score was 3.9 and the median was 3.0 (IQR = 
5). The kurtosis for this pain data was -1.040 and the skew was 0.346, indicating that the data 
does not follow a normal distribution (Field 2018: 23-24).  
Table 4.5: Frequency of pain scores 
 Frequency Percent 
Pain 
Score 
0 8 13.3 
1 8 13.3 
2 8 13.3 
3 7 11.7 
4 3 5.0 
5 6 10.0 
6 7 11.7 
7 3 5.0 
8 6 10.0 
9 2 3.3 
10 2 3.3 













4.2 Quantitative Data Analysis 
4.2.1 Previous Imaging Experience 
All respondents were asked whether they had previously experienced a specific type of whole-
body imaging before. This was to identify whether a previous imaging experience could be 
associated with different acceptance scores, in comparison to those who were experiencing an 
imaging technique for the first time. Using the Mann-Whitney U test, no statistically significant 
difference was found in acceptance scores between those that had previously experienced 
whole-body imaging, and those that had not for all survey constructs. The results closest to a 
critical p = 0.05 were ‘pain’, p = 0.137 and ‘stress’ p = 0.186. 
4.2.2 Analysis of Ordinal Constructs  
Table 4.6 uses descriptive statistics to show the reported median scores for each construct 
against each imaging modality (the list of constructs is available in table 3.2). These descriptive 
results show the reported median scores for each imaging modality to be either the same, or 
similar to one another. Figure 4.1 is a box plot illustrating the range of scores for the construct 
‘overall experience’ and shows the reported scores to be similar for each imaging modality. 
These descriptive statistics demonstrate high acceptance of whole-body imaging with median 
scores of 4 for ‘overall experience’ of each imaging modality. The median score for ‘staff 
support’ was 5, indicating respondents experienced excellent staff support for each imaging 
modality. This result will be explored in context with the qualitative data in chapter 4.4. Median 
scores for the constructs ‘prior worry’, ‘stress during’ and ‘claustrophobia’ were all either 1 or 2, 









































































































N Valid 48 48 49 49 49 47 48 48 49 
Missing 1 1 0 0 0 2 1 1 0 
Median 
Score* 
2 4 0 1 1 4 5 3.5 4 
Range 4 4 10 4 4 4 4 3 3 








N Valid 32 32 32 32 32 32 32 32 32 
Missing 0 0 0 0 0 0 0 0 0 
Median 
Score* 
1 4 1 1 1 4 5 3 4 
Range 4 3 10 4 4 4 3 4 2 






N Valid 40 40 40 40 40 40 40 40 40 
Missing 0 0 0 0 0 0 0 0 0 
Median 
Score* 
2 5 1 2 2 4 5 3 4 
Range 4 2 10 4 4 4 2 4 4 






N Valid 120 120 121 121 121 1119 120 120 121 
Missing 1 1 0 0 0 2 1 2 0 
Median 
Score* 
2 4 1 2 2 4 5 3 4 
Range 4 4 10 4 4 4 4 4 4 
IQR 1 1 4 1 1 2 1 1 1 
*Possible range of scores for all constructs was 1-5, except ‘pain during’ where the range of 
scores was 0-10. Zero indicated no pain, 10 indicates maximum pain. 
† For these four constructs a low score indicates high acceptance (e.g. little worry or stress 
experienced), and a high score indicates low acceptance (e.g. a greater amount of worry or 
stress experienced). 
‡ For these four constructs a high score indicates high acceptance (e.g. greater support or 






Figure 4.1: A box plot demonstrating the median scores and IQR for overall experience. 
 
The 9 constructs investigated with ordinal data were analysed using the Kruskal-Wallis test to 
demonstrate any variance in the scores recorded for each imaging modality. 7 of the survey 
construct scores did not vary between imaging modality. These were ‘prior worry’ p = 0.200; 
‘understanding’ p = 0.700; ‘pain during’ p = 0.464; ‘control’ p = 0.509; ‘support’ p = 0.373 and 
‘overall experience’ p = 0.551. 
Significant variation in the distribution of the acceptance scores reported by respondents was 
found for the constructs of stress experienced during imaging, p = 0.008, and claustrophobia 
experienced during imaging, p = <0.001. These two constructs will undergo post-hoc analysis.  
Post-hoc Analysis for Stress Experienced During Imaging 
Figure 4.2 shows the distribution of reported scores for the stress experienced during imaging. 
The median scores reported for RSS and LD-WBCT were 1 (IQR = 2), and for WB-MRI the 
median score was 2 (IQR = 3). Analysis with the Kruskal-Wallis test showed the stress 








Figure 4.2: A box plot demonstrating the median reported scores and IQR for stress 
experienced during imaging. 
 
 
The scores reported for ‘stress’ during imaging were compared against all three imaging 
techniques, as part of a pairwise analysis using the Kruskal-Wallis test. WB-MRI scores were 
higher than LD-WBCT scores; H = -22.275, p = 0.011, r = -0.343. There was no statistically 
significant difference in the reported scores for between LD-WBCT and RSS; H = 6.202, p = 
1.00, r = 0.095, or WB-MRI and RSS; H = -16.073, p = 0.057, r = -0.311. For WB-MRI the effect 
sizes, r, were calculated to be greater than 0.3 supporting a strong degree of variation in scores 
reported by participants that experienced this imaging technique. 
Post-hoc Analysis for Claustrophobia 
Figure 4.3 shows the distribution of reported scores for the claustrophobia experienced during 
imaging. The median scores reported for RSS and LD-WBCT were 1, and for WB-MRI the 
median score was 2. For respondents reporting upon WB-MRI, the stress experienced was 
greater than the stress reported during LD-WBCT or RSS, H (df 2) = 24.876, p = <0.001. 






Figure 4.3: A box plot demonstrating the median scores and IQR for claustrophobia 




Claustrophobia scores were compared against all three imaging techniques as part of a 
pairwise analysis using the Kruskal-Wallis test. The scores reported for ‘claustrophobia’ during 
imaging for WB-MRI were higher than RSS; H = -29.853 p = <0.001, r = -0.457, and LD-WBCT; 
H = -33.6 p = <0.001, r = -0.511. These effect size scores were both greater than 0.45, 
supporting a strong degree of variation. There was no statistical difference in the reported 
scores for ‘claustrophobia’ between LD-WBCT and RSS; H = 3.747, p = 1.00, r = 0.057.  
  





4.2.3 Analysis of Pain Experienced During Imaging 
In chapter 4.1.4 the pain experienced by respondents was explored (table 4.5). Similar 
descriptive statistics for the pain experienced during whole-body imaging have been produced 
below in table 4.7. The mean pain score across all imaging modalities was 2.31 (IQR 4). For 
each imaging modality mean pain scores were RSS = 1.9 (IQR 3); LD-WBCT = 2.25 (IQR 5); 
WB-MRI = 2.85 (IQR 6). Figure 4.4 illustrates the range of pain scores reported for each 
imaging modality. The kurtosis for this pain data was 0.196 and the skew was 1.212, indicating 
it should be analysed with non-parametric statistical models (Field 2018: 23-24). No pain was 
reported for 47.1% of the imaging experiences indicating that the majority of respondents did 
not experience additional pain. Pain scores of 6 or more were still reported for 18.2% of 
recorded imaging experiences. 
Table 4.7: Frequency of pain scores reported during imaging 
 
 Frequency Percent 
Valid 0 57 47.1 
1 14 11.6 
2 13 10.7 
3 4 3.3 
4 3 2.5 
5 8 6.6 
6 4 3.3 
7 6 5.0 
8 5 4.1 
9 1 .8 
10 6 5.0 
Total 121 100.0 
 
In chapter 4.2.2 it was demonstrated that there was no significant variance in the pain 
experienced across all three whole-body imaging modalities, H (df 2) = 1.537, p = 0.464. Figure 
4.4 shows the median scores and IQR reported for pain with each imaging modality and shows 
the pain experienced across each imaging modality to be similar. Outliers that are 1.5 times 









Each participant's reported baseline pain score was compared with their reported pain score for 
each imaging modality they had experienced using the Wilcoxon signed-rank test (Field 2018: 
297-300). The results of this analysis showed that the pain scores reported by respondents 
during imaging were significantly lower than the respondents baseline pain, T = -6.73, p = 
<0.00, r = -0.61. This result demonstrates that the imaging experience did not cause an 
increase in respondent pain. 
To better understand which respondents experienced higher levels of pain during imaging, the 
respondents’ baseline pain scores and pain during imaging scores were grouped into three 
categories recommended by Hartington et al. (2018: 87). Pain scores of 0-3 were categorised 
as low pain, 4-6 as moderate pain and 7-10 as high pain. By categorising the data this way, it 
was possible to review the descriptive statistics to see which group mostly reported high pain. 
57 of the 59 respondents who reported low baseline pain also reported low pain scores during 
imaging. 35 respondents reported moderate baseline pain, 21 of which reported low pain during 
imaging and 13 reported moderate pain during imaging. 16 of the 27 respondents who reported 
severe baseline pain, also reported severe pain during imaging. However, there were 10 






instances when those that reported severe baseline pain reported low pain during imaging. 
These descriptive statistics demonstrate that severe pain during imaging was experienced 
mostly by the group who already reported severe pain as a result of their condition. Likewise, 
the group who reported low pain as a result of their condition also reported low pain when 
undergoing imaging. These descriptive statistics are detailed in table 4.8. 
Table 4.8: Cross-tabulation of categorised pain scores reported at baseline and during 
imaging 
 
Pain Experienced During Imaging 





Baseline pain Low pain Count 57 1 1 59 
% of Total 47.1% 0.8% 0.8% 48.8% 
Moderate 
pain 
Count 21 13 1 35 
% of Total 17.4% 10.7% 0.8% 28.9% 
Severe 
pain 
Count 10 1 16 27 
% of Total 8.3% 0.8% 13.2% 22.3% 
Total Count 88 15 18 121 
% of Total 72.7% 12.4% 14.9% 100.0% 
 
 
The results of these descriptive statistics are further supported by correlating reported baseline 
pain scores with the pain that they have experienced during imaging. Using Spearman’s 
correlation coefficient (Field 2018: 351) a significant positive correlation was found; rs = 0.644, p 
= < 0.001. This indicates that respondents who reported a higher level of pain as a result of their 




4.2.4 Length of Examination 
Cross-tabulation of each imaging modality against the number of respondents who reported 
difficulty with the length of the examination provides further descriptive statistics, summarised in 
table 4.9. Difficulty with the length of the examination was recorded 23 times out of 121 overall 
imaging experiences (19%). 14 of these were associated with WB-MRI (11.6%) and the 
remaining 9 were associated with either RSS or LD-WBCT (7.4%). 14 respondents out of 40 
(35%) who had experienced WB-MRI stated that they had difficulties with the length of this 
examination, a large proportion of the WB-MRI sample. 
Table 4.9: Cross-tabulation of difficulties with the length of imaging against each 
modality 
 
Difficulties with Length 
Total Yes No 
Imaging 
Modality 
RSS Count 5 44 49 
% within Imaging Modality 10.2% 89.8% 100.0% 
% of Total 4.1% 36.4% 40.5% 
LD-
WBCT 
Count 4 28 32 
% within Imaging Modality 12.5% 87.5% 100.0% 
% of Total 3.3% 23.1% 26.4% 
WB-MRI Count      14 26 40 
% within Imaging Modality 35.0% 65.0% 100.0% 
% of Total 11.6% 21.5% 33.1% 
Total Count 23 98 121 
% within Imaging Modality 19.0% 81.0% 100.0% 
% of Total 19.0% 81.0% 100.0% 
 
To demonstrate a relationship between pain and difficulty with the length of the imaging 
examination, a second set of descriptive statistics were produced comparing these two 
variables. Table 4.10 shows that respondents who reported difficulties with the length of an 
examination reported a range of low, moderate and severe pain scores. For WB-MRI, 8 of the 
14 respondents who had difficulty with the length of this examination experienced low pain, and 
nearly half of the respondents who had difficulty with any imaging examination also experienced 
low pain. This indicates that pain may not always be the primary factor that effects a 





Table 4.10: Cross-tabulation of respondents who stated they had difficulty with the 
length of imaging against the pain experienced during imaging 
 
Pain During Imaging  
Total Low pain Moderate pain Severe pain 
Imaging 
Modality  
RSS Count 2 1 2 5 
% of Total 8.7% 4.3% 8.7% 21.7% 
LD-WBCT Count 1 1 2 4 
% of Total 4.3% 4.3% 8.7% 17.4% 
WB-MRI Count 8 2 4 14 
% of Total 34.8% 8.7% 17.4% 60.9% 
Total Count 11 4 8 23 
% of Total 47.8% 17.4% 34.8% 100.0% 
 
To investigate any association between difficulty with the length of each imaging modality and 
each survey construct, a sub-group analysis was performed using the Mann-Whitney U test. For 
the WB-MRI sub-group, respondents who stated they had difficulty with the length of the 
examination reported significantly higher claustrophobia scores than the respondents who did 
not have any difficulty with the length of the examination, U = 65.5, z = -3.562, p = 0.001, r = -
0.563. The results of this analysis with the Mann-Whitney U test are illustrated in figure 4.5, 
which shows two histograms comparing the claustrophobia scores reported for WB-MRI. A 
limitation of this analysis is the small sample size of each group. 
 
Figure 4.5: Histogram of claustrophobia scores reported for WB-MRI, with respondents 




4.2.5 Concerns with the Use of X-rays or Magnetic Fields 
9 out 60 respondents (15%) across 12 of 117 recorded imaging experiences (10.3%) indicated 
concerns regarding the use of either x-rays or magnetic fields. Table 4.11 shows that the 
greatest proportion of these concerns related to RSS where 7 out of 46 respondents (15.2%) 
recorded a concern regarding the use of x-rays for this modality. Analysis with the Mann-
Whitney U test did not demonstrated any difference in the acceptance scores between those 
that had a concern with the use of x-rays, and those that did not. The construct ‘prior worry’ 
demonstrated the highest unadjusted significance value, p = 0.057. 
Table 4.11: Cross-tabulation of concerns about the use of x-rays or magnetic fields 
against each modality 
 
Concern about the 
use of X-
rays/magnets 
Total Yes No 
Imaging 
Modality 
RSS Count 7 39 46 
% within Imaging 
Modality 
15.2% 84.8% 100.0% 
% of Total 6.0% 33.3% 39.3% 
LD-
WBCT 
Count 1 31 32 
% within Imaging 
Modality 
3.1% 96.9% 100.0% 
% of Total 0.9% 26.5% 27.4% 
WB-MRI Count 4 35 39 
% within Imaging 
Modality 
10.3% 89.7% 100.0% 
% of Total 3.4% 29.9% 33.3% 
Total Count 12 105 117* 
% within Imaging 
Modality 
10.3% 89.7% 100.0% 
% of Total 10.3% 89.7% 100.0% 






4.2.6 Survey Tool Validity 
In chapter 3.2.2 it was stated that the construct validity of the survey tool would be assessed 
through convergent and divergent validity (Fayers & Machin 2016: 96-98). Each of the nine 
constructs that was investigated using ordinal data was correlated against the other constructs 
using Spearman’s correlation coefficient (Field 2018: 351-352). The results of this correlation 
are demonstrated in table 4.12, with those that are statistically significant highlighted. 
Correlation coefficients greater than 0.5, or lower than -0.5, have been highlighted orange to 
indicate stronger correlations. Reviewing the data presented in table 4.12 shows where scores 
reported for one construct positively or negatively correlates with scores reported for a second 
construct. This analysis does not demonstrate any causality but supports the validity of the 
bespoke survey tool used for this study. Overall, there were positive correlations between 
overall experience and the constructs ‘understanding’, ‘control’, ‘support’ and ‘comfort’ while 
there were negative correlations between overall experience and the constructs ‘prior worry’, 
‘pain during’, ‘stress during’ and ‘claustrophobia’.  
Whilst this data was produced to demonstrate the validity of the survey tool, it also shows some 
significant results. The construct of stress during imaging gave the strongest positive correlation 
with the constructs ‘worry prior to imaging’, rs = 0.682, and ‘claustrophobia’, rs = 0.590. The 
construct ‘control’ showed strong positive correlations with overall experience, rs = 0.647; 
comfort, rs = 0.595 and support, rs = 0.565. ‘Stress during imaging’ had a strong negative 
correlation with ‘control’, rs = -0.506, and overall experience, rs = -0.536. There appear to be no 






Table 4.12: Spearman’s correlation coefficients for each survey construct 
 

























































































Prior Worry Correlation 
Coefficient 
  -0.063 0.135 .682** .411** -.444** -.200* -.247** -.298** 
Sig. (2-
tailed) 
  0.496 0.141 0.000 0.000 0.000 0.029 0.006 0.001 
Understanding Correlation 
Coefficient 
-0.063   -0.072 -0.154 -0.097 .402** .395** .317** .392** 
Sig. (2-
tailed) 
0.496   0.437 0.093 0.294 0.000 0.000 0.000 0.000 
Pain During Correlation 
Coefficient 
0.135 -0.072   .186* .311** -.263** -0.089 -.478** -.266** 
Sig. (2-
tailed) 
0.141 0.437   0.041 0.001 0.004 0.331 0.000 0.003 
Stress During Correlation 
Coefficient 
.682** -0.154 .186*   .590** -.506** -.287** -.419** -.536** 
Sig. (2-
tailed) 
0.000 0.093 0.041   0.000 0.000 0.001 0.000 0.000 
Claustrophobia Correlation 
Coefficient 
.411** -0.097 .311** .590**   -.411** -0.088 -.361** -.363** 
Sig. (2-
tailed) 
0.000 0.294 0.001 0.000   0.000 0.338 0.000 0.000 
Control Correlation 
Coefficient 
-.444** .402** -.263** -.506** -.411**   .565** .595** .647** 
Sig. (2-
tailed) 
0.000 0.000 0.004 0.000 0.000   0.000 0.000 0.000 
Support Correlation 
Coefficient 
-.200* .395** -0.089 -.287** -0.088 .565**   .443** .449** 
Sig. (2-
tailed) 
0.029 0.000 0.331 0.001 0.338 0.000   0.000 0.000 
Comfort Correlation 
Coefficient 
-.247** .317** -.478** -.419** -.361** .595** .443**   .534** 
Sig. (2-
tailed) 





-.298** .392** -.266** -.536** -.363** .647** .449** .534**   
Sig. (2-
tailed) 





4.3 Qualitative Data Analysis 
Thematic analysis was applied to the 198 text responses according to the method outlined in 
chapter 3.3.8. Figure 4.6 shows the final thematic map that was produced in phase 5. Three 
themes were identified, containing a total of 11 sub-themes.  
 
 




4.3.1 Theme 1: Patient Factors 
A number of factors unique to the individual and independent of the imaging technology were 
identified in the thematic analysis. These subthemes are largely introspective and while they do 
not relate to a specific imaging modality, they are still linked to the patients’ myeloma journey 
and their associated imaging experiences. Direct quotations from the dataset, as they were 
written by the participant, will be used to support the proposed themes, alongside a fully 
anonymised participant identification number. 
Sub-Theme 1: Patients are accepting of imaging and understand its need for diagnosis 
The coding table in appendix 5.6 shows that ‘imaging needed for diagnosis’ was the most 
frequently used code, being used 28 times. Participants indicated a high acceptance of imaging 
due to understanding its need. Imaging appeared to be perceived as a positive tool, as when 
asked about the advantages of imaging many respondents stated that they recognised how the 
imaging and the diagnosis had helped them: 
• “Gives a good picture of the condition of my bones and how much myeloma is in my 
body” (s24).  
• “A useful test used to explain why I was experiencing severe back and rib pain which 
ultimately led to my being diagnosed with multiple myeloma” (s25).  
Other respondents were accepting of imaging from a more pragmatic perspective:  
• “It’s important to realise as a patient these examinations are for benefit of the patient. If 
these scans are required the data that is outputted will aid me, so you need to just get on 
with it” (s40).  
• “As multiple myeloma is incurable I was willing to have any procedure deemed 
necessary to prolong my life and advance treatment” (s50). 
A result that strongly demonstrates the myeloma patients’ acceptance is that each of the 60 
respondents, for all 121 imaging recorded experiences, stated that they would be prepared to 
undergo that whole-body imaging technique again if necessary. Although the thematic analysis 
shows that patients are highly accepting of the need for imaging, this should not overshadow 




Sub-Theme 2: Patients develop coping mechanisms 
Respondents were able to develop coping mechanisms to improve their intrinsic acceptance of 
whole-body imaging and counteract any associated burdens. The coding around coping 
mechanisms was recorded seven times and related to WB-MRI most frequently. Participants 
reported that concentration was an important part of coping with the burden of WB-MRI:  
• “I concentrated throughout to ensure control. It was important that I knew I could call for 
help if needed” (s24). 
One participant, as well as referencing concentration, described a sense of pride at having been 
able to complete a WB-MRI:  
• “I am claustrophobic, so found it very difficult. I was in the scanner for an hour and 
twenty minutes so really had to concentrate to keep calm. The noise was unbelievable 
too. I am proud of myself for getting through it, and hope I don't need to have one again, 
but if I do, at least I know what to expect. I wore a sleep mask, which really helped, as I 
couldn't see how confined the space was” (s31). 
Another participant described some more physical approaches, such as breathing or singing, as 
a coping mechanism: 
• “Just needed to get myself into a good happy space whilst the process was on going.  
Practising [sic] breathing exercises and keeping my eyes closed and singing to myself 
helped” (s40). 
Only two respondents reported that they required the support of an orally ingested sedative 
prescribed by their doctor to be able to complete their WB-MRI: 
• “I was very anxious before and during the scan. my doctor had to prescribe me a 
sedative as I really struggle with these scans.” (s09). 
Whilst the use of oral sedation could have an effect on an individual’s perception and 
experiences, the need for sedation relates to high levels of scan related anxiety and these 




Sub-Theme 3: Pain and bone damage are primary concerns 
Bone damage was coded 16 times, and the words ‘bone’ or ‘bones’ were used 17 times across 
the dataset. Reviewing the text provided by respondents demonstrates a strong theme towards 
individual concerns about bone damage, whilst understanding the utility of imaging in being able 
to visualise the bone damage: 
• “I was happy to have an MRI to see if I had any more Myeloma damage to my vertebrae” 
(s46). 
• “Reassuring to know damage to bones limited to one area.” (s50). 
Pain has been included in this theme as respondents frequently discussed pain and bone 
damage in unison. ‘Pain’ was referred to 30 times, the second most frequently occurring word 
(see appendix 7). The necessity of identifying bone lesions that cause pain appears to be well 
understood by those living with myeloma: 
• “Needed to get adequate images of my bones, inc any lesions. Last one 1 month ago 
showed a new one following some recent pain. This indicated a potentially impending 
spinal cord compression for which I was given a short course of Radiotherapy” (S51). 
Some of the pain reported by respondents was exacerbated by the imaging experienced. One 
respondent shared their experience of having to change position for RSS: 
• “Standing for some xrays was painful, as was lying flat due to spinal fractures” (s35). 
Another respondent shared a similar experience of increased pain through having to lie still for a 
WB-MRI: 
• “Due to spinal damage caused by the Myeloma, I am unable to lie flat and it was very 
difficult to remain in an acceptable position for the length of the scan” (s26). 
Sub-Theme 4: Results are an additional concern 
The goal of any diagnostic test is to obtain a result for diagnosis. This is well understood by 
patients, and many of the respondents in this survey stated the potential results were frequently 
a source of anxiety. Although the results are a variable that cannot be accounted for it has still 
been included as a sub-theme due to the number of times it was referenced by the survey 
respondents, 15 in total. These references were made in relation to all three whole-body 
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imaging modalities. Two examples of the potential results being a source of anxiety are 
provided below. 
• “Procedure itself wasn't a problem. General anxiety was related to the disease, what the 
scans would reveal” (s50) 
• “Just scared about the result and there is nothing anyone could have done about that. 
Everyone was so kind and professional. There was nothing at all that would have 
prevented my having a repeat scan, the scariest thing is what it may have shown and 
equally the same for any repeat scans” (s02). 
4.3.2 Theme 2: Factors that Improve Acceptance of Whole-Body Imaging 
The two sub-themes that will be described here are applicable across all three imaging 
modalities and relate to external factors that have a largely positive effect on acceptance. 
Sub-theme 5: Staff providing support 
The word staff was referenced 13 times within the dataset, although this is in relation to both 
positive and negative experiences. However, positive staff experiences were coded four times 
and appeared to demonstrate how staff support enabled a patient to complete whole-body 
imaging and improve their overall experience. One respondent documented a burden they 
experienced during WB-MRI, and how staff supported them through explaining the process: 
• “Noises but staff were supportive and explained whole process” (s13). 
The positive impact of staff explaining the imaging procedure and communicating with the 
patient was documented by a second respondent, who linked a full discussion about their 
imaging with a positive impression of staff: 
• “Everything was discussed fully during MRI, CT and x-ray, staff were excellent in all 
departments. Staff consultants and Dr's at Haematology have been fantastic” (s34). 
The base word ‘explain’, including stemmed words such as ‘explained’, was used eight times 
throughout the dataset. This indicates that patients feel that there is a value or significance to 
receiving an explanation from the staff guiding them through the imaging process. Within staff 
support, staff providing an explanation and communicating with staff should also be considered 
as factors to improve the acceptance of whole-body imaging across all modalities.  
86 
 
Sub-Theme 6: Making patient comfortable 
Whilst it seems intuitive that being physically comfortable will increase the acceptance of any 
whole-body imaging technique, its importance becomes more pronounced when considered 
against other factors that may hamper acceptance. If a patient is not comfortable, then the 
factors that reduce the acceptance of whole-body imaging may become prevalent throughout 
the entire imaging experience. One respondent stated the devices that were strapped across 
them as part of their WB-MRI improved their comfort and reported it as an advantage: 
• “More comfortable as lying down and 'held' in position” (s04). 
Another respondent also stated not having to keep changing positions was an advantage of 
WB-MRI: 
• “Do not have to move into different positions” (s09) 
One respondent specifically referenced the comfort of LD-WBCT as being one of several factors 
that improved acceptance: 
• “With the new volume scanner, the speed was amazing and the mattress was very 
comfortable. Had I been in pain on one of the old scanners I think it could have been 
quite tricky.” (s02). 
The theme of comfort also has the potential to reduce patient acceptance, when discomfort 
becomes pain, which has already been identified as impacting the acceptance of imaging in 
sub-theme 3. The word ‘uncomfortable’ was referenced 11 times in the dataset. In addition, the 
base word ‘position’ and related stem words were referenced 12 times, primarily used by 
respondents to document the experience of being positioned or having to change position for 
their whole-body imaging. Within the dataset this was frequently associated with some 
discomfort. The code ‘difficulty with positioning for RSS’ was used 14 times, with 9 of the 48 
respondents (18.8%) who had experienced this modality documenting discomfort associated 
with the physical manipulation necessary for RSS and reporting it as a disadvantage: 
• “Difficulty in standing due to back pain from lying flat (pain started when moving, none 
during xray)” (s27). 




4.3.3 Theme 3: Factors that Reduce Acceptance of Whole-Body Imaging 
The four sub-themes that will be described here are applicable across all three imaging 
modalities and relate to factors that negatively affect acceptance and are outside the patients’ 
control. 
Sub-theme 7: Negative staff support 
As sub-theme 5 identified staff support as being a factor that improves acceptance of whole-
body imaging, it is therefore intuitive that the opposite would reduce patients’ acceptance of 
whole-body imaging. This polar effect was not evident for every factor that had either a positive 
or a negative influence on acceptance, but was highly evident in the overall theme of staff 
support, so has been reported separately. 
As stated previously, the word ‘staff’ was used 13 times in the dataset, and whilst the concept of 
negative staff support was coded only 7 times by 5 respondents, there was some significant 
feedback regarding the apparent lack of emotional support or empathy. 
• “Some are more sympathetic than others. To you this is a life changing diagnosis and 
every procedure can be worrying” (s50). 
• “Concerns about pending diagnosis. Staff were very practical but not emotionally 
supportive” (s13). 
• “Staff being more patient focused than task focused. More explanation throughout the 
procedure” (s38). 
Sub-theme 5 indicated the value of healthcare staff providing service users with a full 
explanation. Conversely, three respondents indicated how a lack of explanation or information 
negatively impacted their imaging experience, as demonstrated in the example below: 
• “Not explained how long I was to be in MRI” (s14). 
Sub-theme 8: Staff task-focused or manhandling patients 
An additional sub-theme emerged around the concept of staff support regarding the physical 
positioning that the radiographer is required to perform upon the patient in order to obtain the 
full range of radiographic projections for RSS. When asked what could improve the experience 
of RSS, two respondents reported a negative perception of this staff interaction: 
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• “Staff to take it at individual pace and not rush. Explain and allow individual to take 
positions rather than doing it for the individual” (s60). 
• “Radiology staff [redacted] were too task focused. They were more interested in getting 
the images they needed than the discomfort it was causing me. Lots of moving me 
about, at times quite roughly” (s38). 
Although only two respondents reported this type of experience, the qualitative data they 
provided demonstrates the significant detrimental impact this had on their acceptance of RSS. 
Sub-theme 9: The length of the whole-body imaging 
Whilst the length of a whole-body imaging examination in itself appears to have little effect on its 
acceptance, when combined with other factors such as discomfort or claustrophobia, the length 
of an examination then has a greater pronounced effect. Time, and similar words, were 
recorded 26 times in the data set, the third most frequently used set of words. ‘Difficulty with the 
length of the WB-MRI’ was the second most frequently used code, being used 26 times. 18 
respondents documented some difficulty with the length of a WB-MRI examination, in 
conjunction with other factors: 
• “It’s quite hard to remain still and stay comfortable for such a long time, especially when 
you a covered from head to toe. It also gets a little claustrophobic when they are 
scanning your head. It’s manageable but can be tough” (s53). 
• “Being enclosed and still for a lengthy period was difficult” (s19). 
• “Very noisy and the length of time it takes can be unsettling. Seems never ending first 
time and some would definitely find it claustrophobic” (s29). 
Other participants recorded anxiety that being unable to complete the WB-MRI due to the length 
of the examinations could impact their treatment: 
• “Stress was caused by the concern I would not be able to stay in position for the time 
required and this may jealousies [sic, jeopardise] my stem cell transplant going ahead” 
(s26). 
• “There is a tension that builds up - if you stop for any reason then they have to start from 




Whilst some respondents documented the perceived diagnostic accuracy of WB-MRI as an 
advantage, 5 respondents felt that the relative speed of RSS was its main advantage over other 
imaging modalities: 
• “Can be done in XRay so possibly much quicker wait time than MRI” (s33). 
• “Quick and relatively easy” (s39). 
Conversely, four respondents found the length of RSS to be difficult, mainly in conjunction with 
the discomfort experienced due to positioning for the radiographs or a lack of information 
regarding the length of the examination: 
• “Staff moving me about roughly, seemed to take ages and I got no real indication of how 
long it was all going to last” (s38). 
• “Takes a long time, Some postions [sic] are difficult to move into with bone damage and 
pain” (s09). 
• “Was difficult standing so long and quite difficult positioning myself” (s53). 
4 respondents perceived the speed of LD-WBCT to be one of its main advantages: 
• “Fast, low dose with new scanners, not claustrophobic” (s02). 
Sub-theme 10: Noise produced by the scanner 
The radiographs required for producing a series of x-rays for RSS produce very little noise, 
whilst the noise produced during an MRI scan is well documented (Graham, Cloke and Vosper 
2011: 294). ‘Noise’ was coded 18 times in this dataset, and the word was used 10 times. In both 
cases it was most frequently in reference to WB-MRI. One respondent documented how being 
unprepared for the noise of the WB-MRI affected them: 
• “I wasn’t ready for the load banging noises and when it made me jump it was extremely 
sore” (s56). 
Ear protection combined with music being played through the ear defenders are commonly 
employed in most modern MRI systems to help reduce the acoustic noise and improve the 




• “I’ve had two full body MRI’s and the headphones/ music is pretty hopeless. Not an easy 
thing to solve, but it does help as a distraction” (s55). 
• “Better ear protection due to noise of scanner” (s44). 
Anecdotally, it is understood that CT scanners also produce some acoustic noise, but there 
appears to be no documented evidence of the associated sound pressures or its effect on 
patients. Three respondents reported the noise of LD-WBCT to be a disadvantage. One 
respondent explained how the noise impacted the feeling of control during their LD-WBCT scan 
due to the effect it had on communication with staff: 
• “I couldn’t hear what was being said and I doubt that anyone would have heard me if I 
had shouted for them to stop” (s32). 
Sub-theme 11: Claustrophobia 
Many of the respondents' quotes illustrating the previous themes have already referenced 
claustrophobia, a well-documented barrier to MRI acceptance (Munn et al. 2015). Within this 
dataset the concept of claustrophobia was coded 12 times and the word used 17 times. 
Respondents frequently reported difficulties with claustrophobia alongside the length of WB-
MRI, or as an element to having a lack of control during the examination. One respondent 
explained that despite having several WB-MRI scans, claustrophobia is a recurrent issue that 
they have been able to adapt too: 
• “Can be claustrophobic but am learning to cope with this (latest was my 5th in 10 years)” 
(s33). 
Interestingly, two respondents both reported experiencing claustrophobia with RSS and LD-
WBCT. Whilst LD-WBCT can be loosely associated with claustrophobia, it is surprising to hear 
claustrophobia can be associated with RSS. This may indicate that while the physical 
parameters of the imaging modality can affect claustrophobia, it is also intrinsic to the individual 




4.3.4 Summary of Thematic Analysis 
These themes have used the patterns of meaning taken from the participants’ written responses 
to provide a deeper understanding of their experiences, and illustrate what affects the 
acceptance of whole-body imaging. Disadvantages of whole-body imaging, such as pain, 
claustrophobia, the duration of imaging and negative staff support were reported with greater 
frequency than some of the recorded advantages, although the significance attached to these 
disadvantages varied amongst responses. Overall, the advantages reported by respondents, 
such as the benefits of imaging in diagnosis or positive staff support, appeared to outweigh 
reported disadvantages in terms of the importance associated with these benefits. However, 
there are examples where a greater degree of importance is associated with negative 
perceptions, specifically sub-theme 8, staff task-focused or manhandling patients, and sub-





4.4 Results Summary and Triangulation 
The quantitative analysis demonstrates that respondents were highly accepting of all three 
whole-body imaging techniques, with the scores provided for each construct indicating good 
levels of acceptability. The first sub-theme of the qualitative results reinforces this; people with 
myeloma are accepting of whole-body imaging and understand its necessity. 
Differences in acceptance scores were analysed using the Kruskal-Wallis statistical model. 
Although acceptance was high across all three imaging modalities, WB-MRI was associated 
with a greater degree of stress during imaging and claustrophobia. Evidence from the qualitative 
component of the results confirms that claustrophobia is a barrier to acceptance. Whilst 
claustrophobia was predominantly associated with WB-MRI in both the quantitative and 
qualitative analyses, it was also modestly associated with RSS and LD-WBCT. The qualitative 
data highlighted some of the stress and anxiety that WB-MRI can induce, although instances 
where both RSS and LD-WBCT induced stress and anxiety were also documented.  
Pain is frequently reported to be a part of living with myeloma. The qualitative results contained 
several reports where respondents stated the process of whole-body imaging exacerbated pain. 
Although the quantitative data did not demonstrate any statistically significant increase in the 
pain experienced during imaging, or in the pain experienced across the three whole-body 
imaging modalities, the descriptive statistics still indicate pain is a barrier to acceptance for 
individuals that experience it. Statistical analysis showed a significant positive correlation 
between the amount of pain experienced during imaging and the level of baseline pain, 
indicating that individuals who suffer with pain as a result of their condition are more likely to 
experience pain during imaging. Out of 121 recorded instances, severe pain was experienced 
18 times during imaging (14.9%). While this is a low proportion of the sample, the qualitative 
data highlights the impact pain has on those that experience it. 
Difficulty with the length of an imaging examination was documented 23 times out of the 121 
recorded imaging experiences (19%) and was mostly associated with WB-MRI. This result is 
supported by sub-theme 9, although the length RSS was additionally documented as having a 
negative effect on acceptance. Sub-theme 9 indicates that an examinations duration usually 
causes a burden in conjunction with other factors such as pain, claustrophobia, stress or noise. 
Further quantitative analysis supports this, as severe pain during imaging was associated with 
14 of the 23 experiences (60.9%) that indicated difficulty with the length of the examination. Of 
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the 40 respondents who experienced WB-MRI, 14 reported difficulties with the length of the 
examination and were associated with statistically significant higher scores for claustrophobia. 
Whilst there were three open text responses where respondents referred to having previously 
experienced a scan, neither the quantitative or qualitative data provided evidence that a 
previous imaging experience affects the acceptance either positively or negatively. 
Although a small number of respondents indicated concern regarding the use of ionising 
radiation or magnetic fields, statistical analysis did not demonstrate any significant results. An 
association nearing significance was indicated between those who had concerns regarding the 
use of ionising radiation or magnetic fields were also worried prior to imaging, p = 0.057. Whilst 
9 individuals stated concern regarding the use of ionising radiation or magnetic fields, the 
qualitative data did not support this. A small number of respondents indicated an awareness of 
the use of radiation and possible associated risks but were accepting of this in order to facilitate 
diagnosis. 
Both datasets highlight the importance of physical comfort in improving acceptance. The median 
score for comfort across all three imaging modalities was 3, a moderate level of comfort. Whilst 
there was no statistically significant difference in the perceived comfort between each imaging 
modality, comfort negatively correlated to the constructs ‘pain’ and ‘stress’ and positively 
correlated with ‘control’ and ‘overall experience’. The qualitative data provided further insight 
into the impact comfort can have on acceptance, and how improved comfort can reduce the 
pain experienced during imaging. 
The quantitative data indicated the highest perceived level of staff support for all three imaging 
techniques, with a median score of 5. The qualitative results in sub-theme 5 support this by 
highlighting how staff support improves the acceptance of whole-body imaging. Although poor 
staff support was infrequently recorded in either the quantitative or qualitative data sets, sub-
themes 7 and 8 provide further detail regarding the impact negative staff interactions had on 
some respondents’ acceptance of imaging. These sub-themes related to the physical and 
emotional burden that the physical manipulations required for RSS caused for some 
respondents, in association with a perceived lack of empathy from staff. The respondents who 




The qualitative data was able to capture some additional significant detail that was not 
demonstrated in the quantitative data due to the nature of the closed questions. The theme 
regarding respondents concerns of bone damage and the imaging results was prevalent in the 
qualitative data. Whilst this is a variable that cannot be controlled, it is partly supported by the 
quantitative data gathered about pain and is worthy of further discussion. 
No quantitative data was collected regarding recollection of the noise experienced, although it 
was identified as a possible barrier to whole-body imaging in the qualitative data, usually in 
association with WB-MRI. Another theme that emerged from the qualitative data but was not 
identified in the quantitative data was the coping mechanisms that individuals employ to enable 






With the advent of new imaging technologies and improvements in existing technologies, 
ongoing research into the efficacy and use of the whole-body imaging techniques for diagnosing 
and staging myeloma is crucial. In tandem with this, patient experience and the relative 
acceptance of different imaging technologies should be a vital element of research as poor 
acceptance and uptake will have a negative effect on the diagnostic impact of any new 
technology (Evans et al. 2018: 1). Furthermore, understanding the burden that diagnostic 
imaging can place upon the individual will equip healthcare practitioners with an insight into the 
patients’ perspective allowing them to better address possible barriers to whole-body imaging 
(Murphy 2001; 193-194; Munn and Jordan 2011: 326). The work presented in this thesis has 
added to the body of knowledge regarding imaging acceptance, with a unique line of 
investigation into the whole-body imaging techniques used for myeloma.  
5.1 Acceptance, Staff Support, Imaging Results and Control 
The three whole-body imaging techniques investigated all showed high levels of acceptance by 
the respondents that had experienced them. The median scores for ‘overall experience’ were 5 
for each modality, indicating the best possible experience by the majority of respondents, with 
no significant variation between imaging techniques.  
There has been contradictory research into patient preference for WB-MRI over other imaging 
techniques, although all the studies report high scores for satisfaction (Adams et al. 2014; 
Evans et al. 2018; Oliveri et al. 2018). The results presented in this thesis further support high 
acceptance across different imaging techniques, but support the conclusions made by Evans et 
al. (2018: 5) in their investigation into experiences of WB-MRI; acceptance of WB-MRI is lower 
than CT. 
Although Oliveri et al. (2018) assert that WB-MRI was preferred to other whole-body imaging 
techniques, they concurred with Adams et al. (2014) and Evans et al. (2018) in that imaging was 
well accepted but added the important supposition that the perceived usefulness of the imaging 
is a contributing factor to acceptance. The thematic analysis within this thesis confirms this; 
many respondents stated that the ability of imaging to visualise bone disease and damage was 
a key benefit, and its need for managing their condition was well understood. The qualitative 
findings also suggest the myeloma group understands the incurable nature of their condition, 
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which may account for the high acceptance of required whole-body imaging observed within this 
group (Vlossak and Fitch 2008: 145). One of the key indicators of the high level of acceptance 
was that every respondent indicated that they were prepared to have imaging again, even when 
they recorded a negative experience. 
The quantitative data showed the mean scores reported for staff support were 5 for each 
imaging modality, indicating the highest level of support. High staff support scores were also 
associated with greater acceptance scores for all three imaging modalities. Where scores for 
staff support were lower, they were frequently accompanied with informative qualitative data 
that was compiled in sub-theme 7 regarding negative staff support. Whilst a diagnostic 
radiographer is likely to perform upwards of thirty imaging examinations in a single day, the 
radiographer should not discount the patient experience as a result of their workload (Harding 
and Park 2020: 62). During the patients visit, they will only experience that single imaging 
examination and are likely to attach significance to their interaction with healthcare staff. There 
is also potential that a patients experience during one visit will influence their perception of 
future imaging examinations, either positively or negatively. The impact radiographers’ 
behaviour will have on patients must be recognised by service managers and radiographers, in 
spite of increased work pressures. Educating radiographers on the subject of emotional impact 
and some basic techniques to address this in collaboration with service user groups may help to 
address this issue.  
Although the qualitative data shows the utility of imaging to be perceived as a benefit, this is 
contrasted by the significant concern respondents had regarding the diagnostic outcome of 
imaging. While there is nothing that can be done to influence the outcome of imaging, it is 
important to consider the significant source of anxiety that awaiting results produces and to 
consider what methods could be employed to support service users throughout this time. 
Healthcare practitioners should try and consider this burden that patients may experience and 
provide what support they can. 
Whilst the radiographer performing an imaging examination has little influence on the time taken 
for results to be made available, they are in a position to inform the patient of the results 
process and reassure patients that this will be done in a timely and efficient manner. It would be 
ideal for results to be made available immediately but this is impractical, not only because of the 
workload of radiology departments and the reporting radiologist but also because the patients’ 
haematologist may need time to correlate imaging results with other tests to form a clinical 
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opinion. A more realistic method of attempting to reduce this burden is to consider techniques of 
managing the patients’ anxiety whilst awaiting results. Theme 5 of the thematic analysis 
highlighted the value of staff providing patients with explanations, supporting the findings of 
Munn and Jordan (2011). Radiographers interact with patients during every imaging visit and 
the importance of fully explaining the results process to the patient must not be overlooked. A 
survey of 202 patients in the US found the median expectation for results to be 3 days after a 
radiology examination (IQR 5) (Woolen et al. 2018: 276). The research also demonstrated that 
20% of participants found that waiting for radiology test results negatively affected their state of 
mind. Whilst results obtained from the US healthcare system may be inapplicable to the NHS, 
the study still illustrates the burden waiting for results places on patients. Woolen et al. (2018: 
278) established that the majority of the patients in their study would prefer to receive results 
from their primary clinician over the telephone, instead of in person. It is possible that the 
patients perceive this as being the quickest method of receiving the results of their imaging and 
is pertinent in the current healthcare climate with more appointments being conducted over the 
telephone due to the Covid-19 pandemic.  
The NHS (2018) has developed a personalised care operating model that outlines the potential 
benefits of providing patients with healthcare choices and utilising shared decision making 
(SDM) between clinicians and patients. These include improved health outcomes and quality of 
life, as well as increasing the effective use of tailored healthcare resources (Phillips 2020). The 
NHS Long Term Plan states that all cancer patients should have access to personalised care by 
2021. Whether personalised care will be fully realised remains to be seen, but the use of SDM 
for myeloma WBI referrals has the potential to be of great benefit. SDM, alongside educating 
service users on the choices available, would allow for the clinician and patient to collaborate on 
selecting the WBI technique most suited to the patient, whilst also ensuring the clinician obtains 
sufficient data for diagnosis and informing treatment. The SDM approach may help limit imaging 
induced anxiety and improving quality of life outcomes.  
Part of the personalised care model is ensuring that it is not just practical and physical needs 
that are met, but also emotional and social needs (Phillips 2020: 74). This could be extended to 
ensuring service users receive the appropriate emotional support from staff, or receive pertinent 
explanations of the WBI choices available. Within the context of radiology imaging, personalised 
care has the potential to mitigate much of the ‘worry prior to imaging’ or ‘stress during imaging’ 
and other barriers to WBI acceptance that were identified in chapters 4.2 and 4.3.3. The 
benefits of staff providing patients with support were discussed earlier in this chapter, and the 
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personalised care model may provide healthcare staff with the tools required to provide support 
and improve the acceptance of WBI. 
In chapter 3.2.4 the construct of control, and how that can affect the acceptance of whole-body 
imaging was first considered. The importance of identifying whether service users feel ‘in-
control’ or ‘helpless’ during their imaging was recognised by both Salmon (1994) and 
Schönenberger (2009). Within this thesis, the quantitative and qualitative data demonstrated a 
relationship between positive staff support and feeling in control during imaging. Whilst it is 
difficult to confirm causality between these two variables, it is intuitive that being supported by 
healthcare staff will improve a patients’ sense of involvement and feeling of maintaining 
influence over their diagnostic intervention, resulting in an improved psychological state. Further 
evidence of this is shown in the strong positive correlation between control and overall 
experience, and the strong negative correlation between control and stress during imaging. 
Examining what affects perceptions of being in-control would be beneficial in future research, as 
there is the potential to identify means of improving control for service users, with the associated 
positive outcomes and reduction in imaging burden. SDM, as part of a personalised care model, 
may be an effective method of giving patients control of their imaging that could be implemented 
without much difficulty and would be worthy of further investigation.  
5.2 Claustrophobia, Stress Experienced During Imaging and Coping Mechanisms 
Claustrophobia is an anxiety-related disorder that is triggered by enclosed spaces (Eshed et al. 
2007: 401). It is a well-documented phenomenon during imaging and has been discussed 
throughout chapter 2.5 (Munn et al. 2015). The results presented in chapter 4.2.4 demonstrated 
that respondents perceived WB-MRI to be more claustrophobic than RSS or LD-WBCT. In spite 
of this, the median score for claustrophobia experienced during WB-MRI was 2, indicating a low 
incidence of claustrophobia across the sample. These results show that while WB-MRI was 
perceived as being more claustrophobic than other imaging techniques, it was by a small 
amount and is still an acceptable imaging modality. Only one participant recorded WB-MRI as 
being less claustrophobic than either RSS or LD-WBCT. Whilst many people refer to having 
feelings of claustrophobia, it doesn’t affect everyone. Nevertheless, the thematic analysis 
illustrates the impact it has on some individuals which should be recognised so that they can be 
supported with possible coping mechanisms which will be reviewed within this chapter. 
99 
 
Stress and anxiety during imaging have been explored by other research using validated 
instruments to measure this phenomenon, such as the STAI-S. Bauml et al. (2016: 110-113) 
argue that while previous research had indicated that a reassuring scan result would diminish 
anxiety, they found that for oncology patients the associated stress could last beyond the 
imaging experience. The prevalence of scan related anxiety varies across different studies but 
clearly has a significant impact on those affected by it (Al-Dibouni 2019: 23). The results 
presented in this thesis showed that WB-MRI was perceived as being significantly more 
stressful than either RSS or LD-WBCT. Again, acceptance scores were still high for WB-MRI 
with the median reported score for stress being only 2. 
As claustrophobia is known to be an anxiety disorder (Eshed et al. 2007: 401) it is perhaps 
unsurprising that this study found a strong correlation between claustrophobia and stress 
experienced during imaging. Recognising this link is important so that healthcare practitioners 
can help service users manage these burdens or refer for an imaging method that is more 
tolerable to that individual, if appropriate to do so. As stated in the previous section, the results 
demonstrated that patients who felt ‘in-control’ during their imaging experience did not record 
stress or claustrophobia. Exploring this relationship further has the potential to allow for 
techniques to be developed that could reduce these negative states and associated burdens, 
potentially improving the acceptance of WB-MRI. Adopting the personalised care model (NHS 
2018) has already been discussed as one possibility that has the potential to place patients ‘in 
control’ of their imaging examination. In the context of MRI, this would entail allowing the patient 
to be involved in choosing that specific modality, and having a healthcare practitioner work 
through any queries or concerns well in advance of the imaging appointment. While the 
radiographer is likely to be best placed to do this due to their detailed knowledge of the 
examination, the referring clinician may also be able to fulfill this role. In current practice, the 
patient will be told they are being referred for a specific imaging examination during 
consultation. They will then receive an appointment with accompanying information, prior to 
attending a number of days or weeks later. Between their consultation and the actual 
appointment patients may have any number of queries or concerns. While they may speak to 
clerical staff to amend appointments, additional resources could help inform the patient of what 
to expect from their imaging. Such resources could include digital platforms that portray a 
realistic imaging experience, or the opportunity to discuss the appointment with a radiographer. 
A barrier to this approach would be the additional resources required in an already burdened 
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health service that is focused on cutting costs while improving efficiency and capacity (Phillips 
2020: 72).  
Theme 2 of the qualitative results explored some of the coping mechanisms that respondents 
had developed that assisted them with completing a challenging imaging experience. Physical 
aids such as listening to music, eye masks or the ability to summon help are one form of coping 
mechanisms. All MRI systems employ a call bell system that the patient can use to contact the 
radiographer and abandon the scan if necessary. Having this mechanism should return some 
feeling of control to the service user, assuming they are fully briefed regarding its use, and 
understand that they remain in control of their being inside the scanner. Relaxation exercises, 
such as breathing, singing or concentrating on maintaining control were reported, and it is 
interesting to see control being referred to once again. Although knowledge of evidence-based 
coping techniques might be considered outside the remit of radiographers, pursuing 
radiographer training in this area, in collaboration with appropriate professions, could lead to a 
brand new approach to how patients are guided through their imaging experience. Research 
into coping strategies employed to prevent the need for sedation in pediatric MRI could inform 
new approaches.  
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5.3 Pain, Length and Noise of the Imaging Examination 
Those living with myeloma often experience increased and significant pain (Vlossak and Fitch 
2008: 145). The demographic data collected in this study supports this, with 33% of 
respondents reporting scores that are shown to have a detrimental effect on an individuals’ daily 
life (Harrington et al. 2018: 87). While imaging did not cause an increase in pain across the 
group, individuals that reported higher pain as a result of their condition also experienced 
greater pain during imaging. The pain experienced during imaging was a key component of sub-
theme 3 of the thematic analysis. Pain was also identified as a barrier to imaging during lengthy 
examinations in sub-theme 9, or where physical manipulations were required as identified in 
sub-theme 8 regarding staff manhandling patients. While pain may not be prevalent, it still has 
the potential to be a significant barrier to whole-body imaging. It is therefore crucial that pain is 
mitigated as much as possible prior to imaging. This could be done through pain control 
medication provided by the primary clinician, or through attempting to improve patient comfort 
during imaging. Sub-theme 6 of the thematic analysis established that ensuring comfort 
improves the acceptance of whole-body imaging. This can be attributed to ensuring that the 
whole-body imaging examination does not cause an increase in pain, therefore negatively 
impacting acceptance. Although the survey data demonstrated no significant difference in the 
perceived comfort of each imaging modality, a number of respondents indicated they found LD-
WBCT and WB-MRI to be the most comfortable due to being able to lie down in a stationary 
position. 
Although difficulty with the length of imaging was only recorded 23 times across 121 
experiences, 14 of these were associated with WB-MRI. The qualitative data was able to 
explore the reasons why the length of an imaging examination affects its acceptance. Sub-
theme 9 highlighted how respondents experienced difficulty with the length of an imaging 
examination when it was in association with other burdens such as pain, claustrophobia or 
noise; the length of imaging of itself was not perceived as being a burden. Some respondents 
documented the stress caused by having to remain still for a lengthy period of time during WB-





It is well understood that MRI produces significant noise that is frequently reported to cause 
some discomfort and has the potential to cause hearing damage (Graham, Cloke and Vosper 
2011). A number of different MRI systems produced by a range of manufacturers exist and 
these all provide some form of ear protection, the specifics of which may be dictated by local 
practice. It is the experience of the author that headphones are the most common ear 
protection. Earplugs are sometimes used instead of, or in addition to, headphones. Sometimes 
music or radio can be played through the headphones, although the effectiveness of this is 
unclear. Some respondents commented that while music is helpful, it was insignificant over the 
noise of the scanner. Given the broad range of individual tastes, possibilities for offering a 
choice of music or radio could be considered to improve the effectiveness of this distraction 
technique. 
5.4 Use of X-rays and Previous Imaging Experience 
Although a small number of respondents indicated a concern regarding the use of ionising 
radiation, they provided little detail on what the concerns were or if they were addressed at the 
time of the imaging examination. 15% of respondents indicated a concern regarding the use of 
x-rays or magnetic fields, comparable to the research by Heyer et al. (2015: 109). The 
qualitative data demonstrated respondents had an awareness of the potential for harm from 
ionising radiation can cause, but no further detail was given. The Ionising Radiation (Medical 
Exposure) Regulations (IR(ME)R) (Department of Health 2017) were recently updated and have 
a specific focus on service users being made aware of the risks versus benefits of the dose of 
ionising radiation that they have been referred for. How this will be done and by whom is still the 
subject of some debate in clinical practice (Younger et al. 2019: 88-89). What is clear is the 
need for service users to be informed of the imaging choices available to them and their 
potential impact, compared with the risks of not undergoing diagnostic imaging. This applies to 
all service users requiring radiology imaging, not just those living with myeloma. 
Research by authors including Heyer et al. (2015: 111) and Oliveri et al. (2018: 249) indicated 
that a previous imaging experience may improve acceptability of subsequent imaging 
examinations. The results of this thesis did not demonstrate any significant variance in 
acceptance scores between those who had previously experienced a specific whole-body 
imaging technique, and those that had not. If an individual has experienced a particular imaging 




5.5 Disadvantages of RSS 
Other researchers have commented on the discomfort that the physical manipulation for RSS 
can cause (Dimopoulos et al. 2009: 2; D’Sa et al. 2007: 51). The author was unable to identify 
any previous research that attempted to collect data regarding patient acceptance of RSS. 
However, the data presented in this thesis supports the argument that RSS can cause pain for 
some individuals. The author found the qualitative data collected in sub-theme 8, regarding the 
manhandling of patients, to be unsettling. A radiographer is tasked with obtaining diagnostic 
images, but in doing so should consider the needs of their patients and ensure that they are 
treated with dignity. RSS does require physical manipulation of the patient by the radiographer, 
but to have a patient report that they felt ‘manhandled’ indicates a patient-centered approach 
was not adopted which is likely to increase the burden and sense of depersonalisation placed 
upon the patient. Two respondents reported this similar sort of negative experience. Although a 
low number, this burden is completely avoidable if the radiographer were to adopt a 
personalised care approach when obtaining the radiographs (Phillips 2020: 72). Whilst the 
author found these comments disconcerting, it was encouraging to see the data mostly 
demonstrated excellent support provided by the healthcare professionals.  
In chapter 2.3.5 guidelines on myeloma imaging produced by the BJH (Chantry et al. 2017), the 
IMWG (2014) and NICE (2015) showed that RSS was still considered to be an option for whole-
body imaging in the diagnosis of myeloma. RSS was also the most frequently experienced 
whole-body imaging modality in this study. Whilst this may indicate that RSS is the most 
frequently utilised form of whole-body imaging, this is impossible to confirm as insufficient data 
was collected as to when imaging was experienced. It may be that respondents experienced 
RSS in the past but are now more frequently being referred for LD-WBCT or WB-MRI. Since 
this study began the IMWG (Hillengass et al. 2019) have published updated guidance on the 
use of whole-body imaging. LD-WBCT is now recommended over RSS due to its improved 
sensitivity (Hillengass et al. 2019: 303). The IMWG also recognised that LD-WBCT may be 
more comfortable for the patient whilst the dose of ionising radiation is less than twice that of 
RSS. The mean dose of ionising radiation reported locally for LD-WBCT was similar to the 
doses published by other authors for RSS (Chantry et al. 2017: 381; Wayte 2020). The IMWG 
recognises that CT may not be available worldwide and RSS may be used out of necessity 
despite its shortcomings (2019: 303). This does not apply to the NHS however, as IPEM 
identified 298 CT scanners in 117 surveyed trusts (2015: 5) so availability of CT equipment 
should not be an issue. Mian and McCurdy (2020: 10) commented on the latest guidance 
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published by the IMWG (Hillengass et al. 2019). They argued that there is insufficient data to 
support the routine use of either WB-CT or WB-MRI. Furthermore, they discuss the wide 
variation amongst Canadian physicians’ preferences regarding the whole-body imaging 
methods, and whether it is an efficient use of resources to continue using a more expensive test 
when a cheaper alternative may still suffice. However, as stated in chapter 2.4, the guidelines 
on the diagnosis and management of myeloma produced by NICE (2016: 74-78) for the NHS 
concludes that there is a strong case that using LD-WBCT or WB-MRI is cost-effective due to 
the benefits of early detection, and negating the need for further detailed imaging if a RSS 




5.6 Limitations and Reflections  
With the primary data collection and analysis concluded, the author is able to reflect upon the 
research methods used and how potential limitations have been addressed. The rationale for 
selecting a mixed-methodology is detailed in chapter 3.1. Having concluded the study it has 
become apparent that this pragmatic approached allowed for collecting the broadest range of 
data possible within the times constraints of the study. The author found that the quantitative 
and qualitative methods complemented each other, as stated by advocates of pragmatism 
(Bryman 2016; Doyle, Brady and Byrne 2016) and enabled a deeper interpretation of results 
that would not have been possible through either a quantitative or qualitative approach.  
Where observational survey studies sit within the spectrum of qualitative, quantitative or mixed-
methods research is not always clear-cut. This study had two related data sets, one analysed 
through quantitative methods, the other through qualitative methods. Nevertheless, the primary 
focus was on the quantitative component and the level of qualitative data, although broad with 
198 separate text responses, was relatively light. Ideally, follow-up interviews would have 
fulfilled the requirements of a mixed-methodology as well allowing for deeper investigation into 
the issues identified. This was not possible due to time constraints, level of participant consent 
and ethical approval. Although the qualitative data lacked the depth that could have been 
obtained through interviews or focus-groups, it has proved worthwhile through triangulation with 
the quantitative component and the conclusions that were drawn through obtaining this data. 
The key rationale for obtaining qualitative data was to ensure individual experiences were not 
lost in quantitative analysis, and the pragmatic method chosen has ensured that. 
The median age of the sample was 58.5 years, lower than the median age of 70 reported for 
myeloma patients in the UK (King, Gooding and Ramasamy 2015: 149). As social media 
accounted for the majority of recruited participants this may account for this deviation from the 
reported demographic. Paper surveys were available to participants recruited from local NHS 
trusts, and to anyone else by request through email. It is possible that this approach limited the 
response rate of participants who were older than 70. 10 out of the 60 participants were aged 70 
years or more. Of these 10 participants, 8 completed the survey online, demonstrating the 
willingness and ability for the older population to engage with digital platforms. It is impossible to 
account for the population that was unable or unwilling to complete the survey due to the 
recruitment methods and the possibility of non-responder bias cannot be discounted (Bowling 
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2014: 180; Bryman 2016: 184-186). Due to the sampling method, there is a possibility that only 
patients who actively engage with their healthcare responded. 
The prevalence of MGUS has been estimated to be approximately 3% in the overall population 
(Bird et al. 2009: 147), and the prevalence of asymptomatic myeloma to be between 0.4% and 
0.9% (Blum et al. 2018: 22). Although the population of respondents in this study does not 
reflect these statistics, this is to be expected as those with MGUS or asymptomatic myeloma will 
require radiological imaging much less frequently than those living with myeloma (Chantry et al 
2017: 382-383).  
Whilst the number of different whole-body imaging modalities experienced have been reported 
on, there are a number of variables here that are impossible to control. Participants were 
recruited from across the UK, and different NHS trusts may only be able to offer certain types of 
whole-body imaging for myeloma. This could be due to the availability of imaging equipment or 
the expertise of healthcare practitioners. At the three NHS sites where the study was open to 
recruitment, each site offered one of the imaging modalities being investigated, with RSS being 
additionally available at the largest site.  
The original sample size estimate of 156 imaging experiences was not met, although post-hoc 
power calculations demonstrated a sufficient sample size to detect significance. Had a larger 
sample size been achieved then it is possible that smaller effects (d = <0.286) may have been 
observed in the data. This means weaker relationships between the imaging modalities and 
survey constructs may have been shown to be statistically significant. 
Whilst the results of this project corroborate with some of the findings from other research, there 
are two key differences that may hamper direct comparison. This study compared three different 
whole-body imaging techniques and treated each as a separate entity, and is the only study to 
investigate the experience of RSS. Other studies only compared two modalities or grouped 
some of the imaging techniques together. Additionally, this study is unique to the perspective of 
the myeloma patient group. Whilst some of the other research may be comparable as the 
experiences of oncology patients were investigated, it should not be assumed that the 
experiences of all individuals living with cancer will be alike. This should be considered when 
comparing the results of this thesis to other research. 
The original study was designed with respondents having had their most recent experience of 
imaging within 6 months of completing the survey in an effort to control for recall bias.  
107 
 
Participants were then invited to share their experiences of other whole-body imaging that 
occurred more than six months ago. 44 participants (73.3%) had their most recent whole-body 
imaging experience within the last 6 months. It was decided to include this data in the analysis 
due to its apparent quality and reliability. The first reason for this was to increase the sample 
size which has the potential to impact the effect size, power or statistical significance of the 
results. The second reason to include these responses was to allow those who have 
experienced imaging and wish to be involved in this research project to be able to share their 
experiences. As discussed in chapter 3.2, there is no standard recall period for measuring or 
understanding phenomena, but the period should be appropriate to the study (Stull et al. 2009: 
940).  
The questionnaire provided a written description of each whole-body imaging modality to assist 
respondents in deciding whether they had experienced that particular examination. The 
possibility exists that a respondent may have given information for a different imaging modality. 
For example, a respondent could have experienced a more conventional MRI scan of a specific 
body part, instead of WB-MRI, and still reported upon it. Although this possibility exists it was 
not evident in the authors review of each completed questionnaire. 
The study was designed to minimise the amount of data collected, including any identifiable 
data to comply with GDPR (2018) and using the guidance published by the HRA (2018a). By 
not collecting identifiable data an opportunity was lost to follow-up respondents through 
telephone interview in this study or future research. Additionally, it is not possible to perform a 
re-test validity check on the questionnaire, to see if similar responses are provided if the 
questionnaire were to be completed a second time (Fayers and Machin 2016: 113-114). Two 
other ways of confirming credibility are triangulation, as discussed earlier in chapter 3.1, and 
debriefing (Murphy and Yielder 2010: 65). This can be done through publication or presenting 
findings to knowledgeable third parties. The process of debriefing will occur after the submission 
of this thesis, but it is the author's intention to publish the results of this project to allow for 
critical review and to disseminate the findings of this research to the patient group involved. An 
example of an infographic designed to inform service users about the project has been 
produced and is available in appendix 9. 
Confirming the criterion validity of a survey instrument is a process of assessing it against a 
known true value (Fayers & Machin 2016: 94). As surveys measure subjective concepts, 
measuring this survey against the results of an established survey instrument is a reliable 
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method of confirming agreement and therefore criterion validity. The adapted survey employed 
in this study was based on two validated surveys measuring patient experiences of imaging 
(Salmon et al 1994; Schönenberger et al. 2007). Although it appears reasonable to assume that 
criterion validity is therefore established, Zarins (2005: 1672) advises caution when assuming 
validity of a survey instrument that has been adapted from its original intended use. Given the 
small scale of this project and the resources available, asking a proportion of respondents to 
repeat the questions seems to offer little advantage but could increase questionnaire fatigue 
and participant burden. 
Reflexivity is an important part of qualitative research methods, including the qualitative 
descriptive approach employed in this study (Bradshaw, Atkinson & Doody 2017: 6; DePoy & 
Gitlin 2011: 229). This process of self-examination allows the author and the reader to interpret 
the trustworthiness and validity of the research by considering whether the researcher’s 
position, views or attitudes may have influenced the study (Saks & Allsop 2013: 449). 
Throughout this thesis the author has been clear in questioning the continued use of RSS, the 
‘traditional’ WBI technique, when newer methods have been developed (see chapters 1.1 and 
2.3.5). It was assisting with developing a new LD-WBCT protocol that led the author towards 
investigating WBI. The author has guided numerous patients through each of these WBI 
techniques, which has steered the author towards their own preconception regarding the 
continued use of RSS. Additionally, the author has observed first-hand the negative impact WB-
MRI can have on patients, as well as the techniques that can help guide a patient through the 
examination so that ultimately their experience is a positive one. It is also the experience of the 
author that the nature of a patients imaging experience can impact their next experience, 
although no evidence was uncovered to support this. 
Recognising their own intrinsic bias, the same questions were asked of all three imaging 
modalities so that the author’s position would not be inferred into the survey tool or the 
participant’s responses. The questionnaire was designed using previously validated survey tools 
and with independent supervisory input. In terms of sampling, the primary goal was to reach the 
largest population possible. The study was available at three sites, each provided one of the 
three WBI techniques being investigated to ensure all three were fairly represented. However, it 
was not possible to account for the responses from social media. 
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The process of thematic analysis requires the author to make interpretations of participants 
responses who made every effort to minimise their own position influencing the results. 
Throughout the two year duration of this study the author’s position has changed somewhat 
from questioning whether RSS should be used, to vehemently appealing for its use to be 
discontinued. The author now finds themselves questioning why LD-WBCT is not employed with 
greater frequency, and has developed further interest in the use of SDM and patient-centered 
care as a means of giving patients control of their imaging so that they might find a challenging 
WBI experience a positive one.  
5.7 Recommendations 
The use of RSS for diagnosing myeloma should be discontinued. The results of this study 
indicate that service users often find this lengthy examination burdensome, uncomfortable and 
painful. As demonstrated in the literature review, and as stated by the IMWG (Hillengass et al. 
2019) it is less sensitive and specific than other whole-body imaging methods. CT and MRI 
equipment is available in the NHS to provide the clinician and the patient alternative whole-body 
imaging methods. Radiology departments that lack the expertise and capability to utilise LD-
WBCT or WBI should receive the support and education required to allow these services to be 
offered. The driver for this change needs to come from radiographers, hematologists and 
radiologists. Disseminating the findings of this thesis will prime these changes in current 
practice. Clinicians and service users should be educated on the modern WBI techniques that 
are available so that the most appropriate can be selected as part of SDM. 
Service users should be provided with a full explanation of what their imaging examination 
entails, including the length of the imaging examination and any associated noise so that they 
can prepare themselves appropriately. For WB-MRI, effective ear protection should be used, 
and music offered whenever possible. 
There is evidence to suggest that service users who feel ‘in-control’ of their whole-body imaging 
examination perceive a reduced emotional burden. Methods of ensuring service users are able 
to maintain control during imaging should be explored by healthcare researchers, especially the 
impact of the personalised care model and SDM. Service managers should work with their 
clinicians and radiographers to ensure they provide a detailed explanation throughout imaging 
and adopt the personalised care model to meet individual needs during the examination (Phillips 
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2020: 75). The use of a call-bell during WB-MRI is an obvious means of ensuring service users 
maintain control, and its use should be fully explained at every imaging appointment. 
For some individuals, the perceived burden of WB-MRI is greater than RSS or LD-WBCT due to 
claustrophobia and feelings of stress. Radiographers and clinical referrers should provide 
coping mechanisms to allow all patients the opportunity to undergo WB-MRI without a 
significant burden. Coping mechanisms may include relaxation or breathing exercises, vicarious 
MRI experience or increased staff support. As radiographers may have limited experience of 
evidence-based coping mechanisms, collaboration with other professions, such as 
psychologists, will be vital to implementing this approach. 
Healthcare researchers should continue to investigate techniques that improve the patients’ 
experience of WB-MRI. This clearly benefits the patients, but also has the potential to reduce 
the number of abandoned imaging appointments and make a valuable diagnostic tool available 
to a greater number of individuals, improving the use of resources for healthcare providers and 
referring clinicians. The utility of a WBI examination is perceived by many individuals to be a key 
benefit, and a driver to completing WBI. Therefore, the advantages of having WB-MRI should 
form part of the patient explanation as it may improve acceptance. Where patients feel unable to 
tolerate WB-MRI, their clinician should employ SDM to offer an alternative whole-body imaging 
technique. 
While pain is subjective to an individual, the service user’s primary physician should consider 
pain management alongside any referral for imaging. Pain is a key barrier to imaging 
acceptance and needs to be managed. The radiographer performing an imaging examination 
should make every effort to improve the patients’ physical comfort to further increase 
acceptance and the likelihood of the imaging examination being completed. 
Patients should be fully informed of the process for obtaining results and given an expectation of 
how long this may take. This should primarily be by the radiographer who has performed WBI, 
The results of imaging should be made available to the patient at the earliest practical 
opportunity, and the onus of responsibility must be taken up by the healthcare providers and 
service managers. Providing results over the telephone is acceptable and has the potential to 
improve the speed that results are given to the patient whilst preventing a physical follow-up 





The work presented in this thesis has described the current whole-body imaging techniques 
employed within the NHS for the diagnosis and staging of myeloma. The effectiveness of each 
technique has been explored in terms of its diagnostic value, and the difficulty in concluding 
whether a particular technique is better than its counterparts has been discussed. Of greater 
importance to this study has been developing an understanding of how service users perceive 
different types of radiology imaging and how they interact with this technology and the 
healthcare professionals who utilise it. The research presented has measured acceptance of the 
different imaging modalities and the factors that influence this by investigating patient 
perceptions of imaging. Through a pragmatic methodology, additional data provided a deeper 
understanding of the enablers and barriers to whole-body imaging which may not have been 
captured with a purely quantitative approach. 
It is hoped that the data obtained in this research project will serve to inform future practice for 
both the physicians that refer patients for whole-body imaging and the radiographers that 
perform the examinations. Through attempting to understand the burdens imaging can place on 
people living with myeloma and understanding the factors that improve the acceptance of 
whole-body imaging, healthcare professionals can better equip themselves to meet the needs of 
service users. This has the obvious benefit of improving the experience of imaging, but also has 
the added benefit of increasing acceptability of imaging which may reduce the number of 
abandoned or difficult examinations (Munn and Jordan 2011). 
The results of this study do not support the continued use of RSS. Given the research available 
and the most recent published guidance, its use in the NHS should be discontinued. The 
ionising radiation exposure associated with LD-WBCT is lower than ever before. Combined with 
the speed of this examination, and the availability of CT scanners in the NHS (IPEM 2015) then 
it should be considered as a possible first line whole-body imaging investigation for myeloma. 
WB-MRI should also be considered as a first line whole-body imaging investigation as despite 





The use of CT in imaging myeloma may have a greater role in the future. There is emerging 
research into the use of dual-energy computed tomography (DECT) for diagnosing myeloma 
(Kosmala et al. 2018). DECT utilises a CT system with two x-ray tubes and detectors, allowing 
for images to be obtained with different energy levels of ionising radiation. This provides 
additional data for different tissue types and has been shown to make the sensitivity of CT 
comparable to that of WB-MRI in measuring myeloma disease in the bone marrow (Kosmala 
2018: 5086-5087). Currently, DECT is unavailable in most NHS hospitals.  
RSS, once the gold standard for myeloma imaging, has been superseded by advanced whole-
body imaging techniques. With the continuous development and innovative implementation of 
new technologies it is possible that current advanced techniques will also one day be replaced, 
perhaps by DECT or some other novel implementation of existing imaging technology. 
Throughout this ongoing development, the patient experience, choice and their acceptance of 
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Appendix 3: Survey Amendments 
Summary of the Major Changes Made to the Questionnaire  
Survey 
Version 





Developed the rationale for using a particular survey instrument in order to make it 






Produced two questionnaires, one using Salmon et al. (1994) as its basis, the 
other using the questionnaire by Schönenberger et al. (2007) for direct 
comparison. The latter was selected. Adjusted the syntax/semantics of some 
questions to prevent them from leading the respondent 
v5 Professional 
Peers 
Included binary responses for some questions. Considered the use of a Visual 




The survey indicators/questions were submitted to five colleagues for feedback. 
Several changes to wording. Addition of questions relating to previous experience 
as this may have a significant impact acceptability. 
v7 Professional 
Peers 
The first draft of the questionnaire using Online Survey (Jisc 2019). The order of 
questions was adjusted to improve the flow of the questionnaire. The patient 




Changes made to syntax, semantics and order of questions to further improve the 
flow and clarity of the survey. 




Please see table on the following page for a list of changes made as a result of 
the PPI feedback. 
v9 Supervisory 
Team 





Provided clarification as to why some questions were being asked. Added 
information regarding the risks to participants and a GDPR statement. 
v11 Professional 
Peers 
Amended terminology of ‘smouldering’ myeloma to asymptomatic myeloma. 
Removed staging data as the patients are unlikely to know, and it is irrelevant to 
the line of inquiry. Instead we have added a question regarding whether 




Incorporated trust and academic institution logos. Added version document dates 







Summary of the Amendments made to the Questionnaire as a Result of PPI 
Feedback 
Reviewer Part of the 
Questionnaire 
to Revise Change 
1 PIS Amended paragraph four regarding how long the survey will take 
2 PIS Clarified contact details 
2 2 Amended gender choices. Non-binary to other 
1, 2 Survey Blank pages to be removed, other errors removed and tidied. 
2 Survey Ensure it is available by post 
3 Survey 
Explore alternative background colours to make text easy to read - I found 
out this is due to black and white printing. 
3 Survey 
Need to make a stronger request for comments, included in a text box on 
page 3. 
4 PIS 
Checked HRA docs to ensure the consent box does not require a 
signature. 
4 19,35,51 
Helplessness; for the open response question include ‘if you did 
(experience helplessness)...’ in order to avoid confusion. (Helplessness 
question has since been changed to being 'in control') 
4 CT 
Ensured that there is a clear explanation of whole-body CT and whole 
body MRI 
5 Survey 
Considered the overall length of the survey. Length is the same but it now 
prints to 20 pages. 
5 11 
Re-visited the issue of inducing concern by answering the survey with the 
supervisory team. 
5, 4 Table 
Two comments on what is required of the table and whether people would 
fill it in. 
4 13a 
Added question about what could be clarified if a respondent did not 
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Group 
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Appendix 6: Frequency of Codes Used for Thematic Analysis 
 
Code Name Frequency code was used 
Imaging needed for diagnosis 28 
Difficulty with length of WB-MRI 26 
Advantages WB-MRI 22 
Advantages of RSS 21 
Advantages LD-WBCT 18 
Noisy 18 
Concerned with bone damage 16 
Stress and anxiety with WB-MRI 16 
Disadvantages WB-MRI 15 
Difficulty with positioning for RSS 14 
Detail and accuracy of imaging 13 
Claustrophobia WB-MRI 12 
Pain WB-MRI 12 
Stress and anxiety with RSS 12 
Disadvantages of LD-WBCT 11 
Disadvantages RSS 9 
158 
 
General positive experience 9 
Remaining still WB-MRI 9 
Fitting of and into equipment 8 
Improve experience WB-MRI 8 
Not claustrophobic 8 
Spread and location of cancer 8 
Coping mechanisms 7 
Difficulty with length of RSS 7 
Pain RSS 7 
Stress and anxiety with LD-WBCT 7 
X-ray risk RSS 7 
Negative staff support RSS 7 
Anxiety about results RSS 6 
Concerned imaging was insufficient 6 
Imaging should be perfomed regularly 6 
Lack of control WB-MRI 6 
Negative staff support RSS 6 
Satisfied with length and speed of RSS 6 
159 
 
Satisfied with length-speed of LD-WBCT 6 
Accepting of imaging despite difficulties 5 
Improve experience LD-WBCT 5 
Able to communicate with staff 4 
Anxiety about results LD-WBCT 4 
Improve experience RSS 4 
Increased risk of cancer with x-ray 4 
Pain LD-WBCT 4 
Positive staff support 4 
Positive view as imaging enabled treatment 4 
Terminal illness 4 
Understanding of LD-WBCT 4 
X-ray risk LD-WBCT 4 
X-rays are necessary - accepting - RSS 4 
Availability of imaging test 3 
Imaging is important 3 
Lack of control LD-WBCT 3 
Lack of control RSS 3 
160 
 
More timely appointment 3 
Music 3 
Sedation 3 
Staff being 'rough' 3 
Staff dependent 3 
Uncomfortable LD-WBCT 3 
Aids clinicians diagnosis and treatment plan 2 
Claustrophobia LD-WBCT 2 
Claustrophobia RSS 2 
Difficulty with length length of LD-WBCT 2 
Feeling weighed down 2 
Kept informed RSS 2 
Kept informed WB-MRI 2 
No previous experience of imaging 2 
Non-invasive examination 2 
Possible concern about metalwork in body with x-
ray 
2 
Previous experience of imaging 2 
Remaining still LD-WBCT 2 
161 
 
Results available quickly - positive 2 
Uncomfortable RSS 2 
Uncomfortable WB-MRI 2 
Understanding 2 
Understanding of WB-MRI 2 
Useful test 2 
All imaging experiences similar 1 
Cleanliness 1 
Comfortable LD-WBCT 1 
Comfortable RSS 1 
Comfortable WB-MRI 1 
Concern over use of magnets 1 
Concern with use of IV contrast agent 1 
Delay prior to imaging appointment 1 
Did prior research about x-ray RSS 1 
Didn't understand what the imaging was for 1 
Do not have to go into a scanner 1 
Human error 1 
162 
 
Insufficient explanation RSS 1 
Kept informed LD-WBCT 1 
Manhandling 1 
No noise 1 
Only one imaging test required 1 
Physically supported 1 
Proud to have completed imaging 1 
Provide feedback 1 
Reassurance from results 1 
Reduced pain 1 
Reduced x-ray exposure 1 
Remaining still RSS 1 
Restarting the scan 1 
Unable to communicate with staff 1 
Unable to complete imaging 1 
Unable to stop examination 1 





Appendix 7: Frequency of Words Used in Open Text Responses 
 
 




scans 5 36 1.80 scan, scanned, scanning, scans 
pain 4 30 1.50 pain, painful, painfully, pains 
time 4 26 1.30 time, timely, times, timing 
mri 3 20 1.00 mri 
bone 4 17 0.85 bone, bones 
claustrophobic 14 17 0.85 claustrophobic 
results 7 15 0.75 result, results 
myeloma 7 15 0.75 myeloma 
see 3 15 0.75 see 
needs 5 14 0.70 need, needed, needs 
staff 5 13 0.65 staff, staffs 
body 4 13 0.65 body 
damage 6 12 0.60 damage 
position 8 12 0.60 position, positioning, positions 
provide 7 12 0.60 provide, provided, provides 
164 
 
still 5 12 0.60 still 
caused 6 12 0.60 cause, caused, causing 
back 4 11 0.55 back 
concerns 8 11 0.55 concern, concerned, concerning, 
concerns 
currently 9 11 0.55 current, currently 
good 4 11 0.55 good, goodness 
long 4 11 0.55 long 
none 4 11 0.55 none 
uncomfortable 13 11 0.55 uncomfortable 
useful 6 10 0.50 use, used, useful, using 
difficult 9 10 0.50 difficult 
lying 5 10 0.50 lie, lying 
noise 5 10 0.50 noise, noises 
quick 5 10 0.50 quick 
scanner 7 10 0.50 scanner, scanners 
less 4 9 0.45 less 
problem 7 9 0.45 problem, problems 
worrying 8 9 0.45 worried, worry, worrying 
165 
 
control 7 8 0.40 control 
diagnosis 9 8 0.40 diagnosis 
explained 9 8 0.40 explain, explained 
feel 4 8 0.40 feel 
give 4 8 0.40 give, gives 
moving 6 8 0.40 move, moving 
spinal 6 8 0.40 spinal 
arthritis 9 7 0.35 arthritis 
help 4 7 0.35 help, helped, helps 
know 4 7 0.35 know 
spine 5 7 0.35 spine 
takes 5 7 0.35 take, takes, taking 
test 4 7 0.35 test, testing, tests 
cancer 6 6 0.30 cancer 
chemo 5 6 0.30 chemo 
claustrophobia 14 6 0.30 claustrophobia 


























Appendix 9: Project Infographic 
 
Multiple Myeloma
Myeloma is a type of bone marrow
cancer usually effecting people over
60.
It causes multiple bone lesion
which are identif ied through 
imaging (scans and x-rays)
UK Demographics
5500 people are diagnosed each
year 
There are estimated to be up to
24000 people living with myeloma
Method
60 participants across the UK
volunteered to complete a
survey and share their
experiences of having whole-





There are three dif ferent types of whole-
body imaging techniques used
Pat ient  Acceptance of Whole-
Body Imaging for Myeloma
Most participants found all types of





This document was produced as part of a research project sponsored by Coventry University and with the involvement of the University
Hospitals of Coventry and Warwickshire NHS Trust and funding from the Society and College of Radiographers
Findings
People understand the need for imaging
There were concerns about being in pain
during imaging, and results of the test
The physical manipulation
required for radiographic
skeletal survey was found to
sometimes be painful and
diff icult to tolerate.
Some types of whole-body imaging take
around an hour. This can increase feelings
of stress, claustrophobia and pain.






Support from healthcare staff has an
important inf luence on the patients
experience and acceptance of all whole-
body imaging.
Recommendations
The routine use of radiographic
skeletal survey should be replaced
with either low-dose whole-body CT
 or whole-body MRI 
Imaging choices should be
tailored to meet an individuals needs
Staff  must provide support 
 and a complete explanation of all
aspects of the whole-body imaging
examination
Patients should be made
comfortable to reduce pain
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